Cover Page
Cover Page - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 21, 2023 | Jun. 30, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Dec. 31, 2022 | ||
Current Fiscal Year End Date | --12-31 | ||
Document Transition Report | false | ||
Entity File Number | 001-36383 | ||
Entity Registrant Name | Five9, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 94-3394123 | ||
Entity Address, Address Line One | 3001 Bishop Drive | ||
Entity Address, Address Line Two | Suite 350 | ||
Entity Address, City or Town | San Ramon | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94583 | ||
City Area Code | 925 | ||
Local Phone Number | 201-2000 | ||
Title of 12(b) Security | Common Stock, $0.001 par value | ||
Trading Symbol | FIVN | ||
Security Exchange Name | NASDAQ | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 5,331.6 | ||
Entity Common Stock, Shares Outstanding | 71,151,340 | ||
Documents Incorporated by Reference | Portions of the registrant’s definitive Proxy Statement for the 2022 Annual Stockholders’ Meeting, which the registrant expects to file with the Securities and Exchange Commission within 120 days of December 31, 2022, are incorporated by reference into Part III (Items 10, 11,12, 13 and 14) of this Annual Report on Form 10-K. | ||
Entity Central Index Key | 0001288847 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2022 | |
Audit Information [Abstract] | |
Auditor Firm ID | 185 |
Auditor Name | KPMG LLP |
Auditor Location | Santa Clara, California |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 180,520 | $ 90,878 |
Marketable investments | 433,743 | 378,980 |
Accounts receivable, net | 87,494 | 83,731 |
Prepaid expenses and other current assets | 29,711 | 30,342 |
Deferred contract acquisition costs, net | 47,242 | 33,295 |
Total current assets | 778,710 | 617,226 |
Property and equipment, net | 101,221 | 77,785 |
Operating lease right-of-use assets | 44,120 | 48,703 |
Intangible assets, net | 28,192 | 39,897 |
Goodwill | 165,420 | 165,420 |
Marketable investments | 885 | 147,377 |
Other assets | 11,057 | 11,871 |
Deferred contract acquisition costs, net — less current portion | 114,880 | 84,663 |
Total assets | 1,244,485 | 1,192,942 |
Current liabilities: | ||
Accounts payable | 23,629 | 20,510 |
Accrued and other current liabilities | 53,092 | 78,577 |
Operating lease liabilities | 10,626 | 9,826 |
Accrued federal fees | 2,471 | 2,282 |
Sales tax liabilities | 2,973 | 2,660 |
Deferred revenue | 57,816 | 43,720 |
Convertible senior notes | 169 | 0 |
Total current liabilities | 150,776 | 157,575 |
Convertible senior notes - less current portion | 738,376 | 768,599 |
Sales tax liabilities — less current portion | 899 | 877 |
Operating lease liabilities — less current portion | 41,389 | 47,088 |
Other long-term liabilities | 3,080 | 7,671 |
Total liabilities | 934,520 | 981,810 |
Commitments and contingencies (Note 10) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 5,000 shares authorized, no shares issued and outstanding as of December 31, 2022 and 2021 | 0 | 0 |
Common stock, $0.001 par value; 450,000 shares authorized, 71,047 shares and 68,488 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 71 | 68 |
Additional paid-in capital | 635,668 | 439,787 |
Accumulated other comprehensive loss | (2,688) | (287) |
Accumulated deficit | (323,086) | (228,436) |
Total stockholders’ equity | 309,965 | 211,132 |
Total liabilities and stockholders’ equity | $ 1,244,485 | $ 1,192,942 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 450,000,000 | 450,000,000 |
Common stock, shares issued (in shares) | 71,047,179 | 68,488,337 |
Common stock, shares outstanding (in shares) | 71,047,179 | 68,488,337 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 778,846 | $ 609,591 | $ 434,908 |
Cost of revenue | 367,501 | 271,099 | 180,284 |
Gross profit | 411,345 | 338,492 | 254,624 |
Operating expenses: | |||
Research and development | 141,794 | 106,897 | 68,747 |
Sales and marketing | 261,990 | 193,929 | 132,413 |
General and administrative | 95,143 | 93,916 | 65,769 |
Total operating expenses | 498,927 | 394,742 | 266,929 |
Loss from operations | (87,582) | (56,250) | (12,305) |
Other (expense) income, net: | |||
Interest expense | (7,493) | (8,027) | (28,348) |
Loss on early extinguishment of debt | 0 | 0 | (6,964) |
Other (expense) and interest income | 4,813 | (8) | 3,034 |
Total other (expense) income, net | (2,680) | (8,035) | (32,278) |
Loss before income taxes | (90,262) | (64,285) | (44,583) |
Provision for (benefit from) income taxes | 4,388 | (11,285) | (2,453) |
Net loss | $ (94,650) | $ (53,000) | $ (42,130) |
Net loss per share: | |||
Basic (in USD per share) | $ (1.35) | $ (0.79) | $ (0.66) |
Diluted (in USD per share) | $ (1.35) | $ (0.79) | $ (0.66) |
Shares used in computing net loss per share: | |||
Basic (in shares) | 69,920 | 67,512 | 64,154 |
Diluted (in shares) | 69,920 | 67,512 | 64,154 |
Comprehensive Loss: | |||
Net Loss | $ (94,650) | $ (53,000) | $ (42,130) |
Other comprehensive loss | (2,401) | (622) | (241) |
Comprehensive loss | $ (97,051) | $ (53,622) | $ (42,371) |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands | Total | Cumulative Effect, Period of Adoption, Adjustment | [1] | Common Stock | Additional Paid-In Capital | Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment | [1] | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment | [1] |
Beginning balance (in share) at Dec. 31, 2019 | 61,544,000 | ||||||||||
Beginning balance at Dec. 31, 2019 | $ 196,458 | $ 61 | $ 351,870 | $ 576 | $ (156,049) | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Equity component of issuance of the 2025 convertible senior notes, net of issuance costs | 154,363 | 154,363 | |||||||||
Purchase of capped calls related to the 2025 convertible senior notes | (90,448) | (90,448) | |||||||||
Equity component from conversion of the 2023 convertible senior notes | (336,592) | (336,592) | |||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares) | 3,015,000 | ||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes | 309,689 | $ 3 | 309,686 | ||||||||
Fair value of Inference assumed unvested stock options for services completed prior to the acquisition | 192 | 192 | |||||||||
Issuance of common stock upon exercise of stock options (in shares) | 558,000 | ||||||||||
Issuance of common stock upon exercise of stock options | 11,656 | $ 1 | 11,655 | ||||||||
Issuance of common stock upon vesting of restricted stock units (in shares) | 1,210,000 | ||||||||||
Issuance of common stock upon vesting of restricted stock units | 0 | $ 1 | (1) | ||||||||
Issuance of common stock under ESPP (in shares) | 169,000 | ||||||||||
Issuance of common stock under ESPP | 11,470 | $ 1 | 11,469 | ||||||||
Stock-based compensation | 64,747 | 64,747 | |||||||||
Other comprehensive loss | (241) | (241) | |||||||||
Net loss | (42,130) | (42,130) | |||||||||
Ending balance (in shares) at Dec. 31, 2020 | 66,496,000 | ||||||||||
Ending balance at Dec. 31, 2020 | 279,164 | $ 67 | 476,941 | 335 | (198,179) | ||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares) | 453,943 | ||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes | (353) | (353) | |||||||||
Partial unwind of capped calls and retirement of common stock related to the 2023 convertible senior notes (in shares) | (69,000) | ||||||||||
Partial unwind of capped calls and retirement of common stock related to the 2023 convertible senior notes | 9 | 9 | |||||||||
Issuance of common stock upon exercise of stock options (in shares) | 389,000 | ||||||||||
Issuance of common stock upon exercise of stock options | 7,402 | 7,402 | |||||||||
Issuance of common stock upon vesting of restricted stock units (in shares) | 1,097,000 | ||||||||||
Issuance of common stock upon vesting of restricted stock units | (1) | $ 1 | (2) | ||||||||
Issuance of common stock under ESPP (in shares) | 121,000 | ||||||||||
Issuance of common stock under ESPP | 15,397 | 15,397 | |||||||||
Stock-based compensation | 108,805 | 108,805 | |||||||||
Other comprehensive loss | (622) | (622) | |||||||||
Net loss | (53,000) | (53,000) | |||||||||
Ending balance (in shares) at Dec. 31, 2021 | 68,488,000 | ||||||||||
Ending balance at Dec. 31, 2021 | $ 211,132 | $ (145,669) | $ 68 | 439,787 | $ (168,412) | (287) | (228,436) | $ 22,743 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2020-06 [Member] | ||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares) | 573,633 | ||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes | $ (280) | $ 1 | (281) | ||||||||
Partial unwind of capped calls and retirement of common stock related to the 2023 convertible senior notes (in shares) | (119,000) | ||||||||||
Partial unwind of capped calls and retirement of common stock related to the 2023 convertible senior notes | 10 | 10 | |||||||||
Issuance of common stock upon exercise of stock options (in shares) | 531,000 | ||||||||||
Issuance of common stock upon exercise of stock options | 8,522 | $ 1 | 8,521 | ||||||||
Issuance of common stock upon vesting of restricted stock units (in shares) | 1,383,000 | ||||||||||
Issuance of common stock upon vesting of restricted stock units | 1 | $ 1 | |||||||||
Issuance of common stock under ESPP (in shares) | 190,000 | ||||||||||
Issuance of common stock under ESPP | 13,413 | 13,413 | |||||||||
Stock-based compensation | 174,218 | 174,218 | |||||||||
Other comprehensive loss | (2,401) | (2,401) | |||||||||
Net loss | (94,650) | (94,650) | |||||||||
Ending balance (in shares) at Dec. 31, 2022 | 71,047,000 | ||||||||||
Ending balance at Dec. 31, 2022 | $ 309,965 | $ 71 | $ 635,668 | $ (2,688) | $ (323,086) | ||||||
[1]Effective January 1, 2021, the Company adopted ASU 2020-06. Accordingly, the Company recorded a net reduction to opening accumulated deficit of $22.7 million and a net reduction to opening additional paid-in capital of $168.4 million as of January 1, 2021 due to the cumulative impact of adopting this new standard. |
CONSOLIDATED STATEMENTS OF ST_2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Adjustment to stockholders' equity | $ (309,965) | $ (211,132) | $ (279,164) | $ (196,458) | |
Accumulated Deficit | |||||
Adjustment to stockholders' equity | 323,086 | 228,436 | 198,179 | 156,049 | |
Additional Paid-In Capital | |||||
Adjustment to stockholders' equity | $ (635,668) | (439,787) | $ (476,941) | $ (351,870) | |
Cumulative Effect, Period of Adoption, Adjustment | |||||
Adjustment to stockholders' equity | [1] | 145,669 | |||
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit | |||||
Adjustment to stockholders' equity | [1] | (22,743) | |||
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital | |||||
Adjustment to stockholders' equity | [1] | $ 168,412 | |||
[1]Effective January 1, 2021, the Company adopted ASU 2020-06. Accordingly, the Company recorded a net reduction to opening accumulated deficit of $22.7 million and a net reduction to opening additional paid-in capital of $168.4 million as of January 1, 2021 due to the cumulative impact of adopting this new standard. |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Cash flows from operating activities: | |||
Net loss | $ (94,650) | $ (53,000) | $ (42,130) |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||
Depreciation and amortization | 44,671 | 38,732 | 25,087 |
Amortization of operating lease right-of-use assets | 10,377 | 8,698 | 5,687 |
Amortization of deferred contract acquisition costs | 41,034 | 26,050 | 16,495 |
Amortization of premium on marketable investments | (90) | 6,385 | 3,090 |
Provision for doubtful accounts | 1,105 | 808 | 754 |
Stock-based compensation | 172,507 | 108,805 | 64,747 |
Amortization of discount and issuance costs on convertible senior notes | 3,743 | 3,957 | 25,738 |
Loss on early extinguishment of debt | 0 | 0 | 6,964 |
Deferred taxes | 3,088 | (6,907) | (178) |
Change in fair value of contingent consideration | 260 | 5,640 | 0 |
Payment of contingent consideration liability in excess of acquisition-date fair value | (5,900) | 0 | 0 |
Tax benefit of valuation allowance associated with an acquisition | 0 | 0 | (2,910) |
Other | 188 | 396 | (147) |
Changes in operating assets and liabilities: | |||
Accounts receivable | (4,899) | (35,986) | (9,958) |
Prepaid expenses and other current assets | 661 | (14,193) | (5,313) |
Deferred contract acquisition costs | (85,197) | (71,380) | (45,454) |
Other assets | (319) | (1,216) | (1,911) |
Accounts payable | 845 | 4,305 | 6,181 |
Accrued and other current liabilities | (8,379) | 20,562 | 9,374 |
Accrued federal fees and sales tax liabilities | 524 | (497) | 1,302 |
Deferred revenue | 13,176 | 10,462 | 7,971 |
Other liabilities | (3,880) | (22,623) | 1,913 |
Net cash provided by operating activities | 88,865 | 28,998 | 67,302 |
Cash flows from investing activities: | |||
Purchases of marketable investments | (435,768) | (680,490) | (620,948) |
Proceeds from sales of marketable investments | 600 | 44,288 | 1,899 |
Proceeds from maturities of marketable investments | 524,568 | 527,940 | 432,579 |
Purchases of property and equipment | (52,272) | (42,216) | (30,422) |
Capitalization of software development costs | (3,899) | 0 | 0 |
Payments of initial direct costs | (266) | 0 | 0 |
Cash paid for an equity investment in a privately-held company | (2,000) | 0 | 0 |
Cash paid to acquire Inference and Virtual Observer | 0 | 0 | (165,338) |
Cash paid to acquire substantially all of the assets of Whendu | 0 | 0 | (100) |
Net cash provided by (used in) investing activities | 30,963 | (150,478) | (382,330) |
Cash flows from financing activities: | |||
Proceeds from issuance of convertible senior notes | 0 | 0 | 728,812 |
Payments for capped call transactions | 0 | 0 | (90,448) |
Repurchase of a portion of 2023 convertible senior notes, net of costs | (34,067) | (24,688) | (200,350) |
Proceeds from exercise of common stock options | 8,522 | 7,402 | 11,656 |
Proceeds from sale of common stock under ESPP | 13,413 | 15,397 | 11,469 |
Payment of contingent consideration liability up to acquisition-date fair value | (18,100) | 0 | 0 |
Payment of holdbacks related to acquisitions | 0 | (5,000) | 0 |
Payments of finance leases | 0 | (612) | (3,715) |
Net cash (used in) provided by financing activities | (30,232) | (7,501) | 457,424 |
Net increase (decrease) in cash and cash equivalents | 89,596 | (128,981) | 142,396 |
Cash and cash equivalents: | |||
Beginning of year | 91,391 | 220,372 | 77,976 |
End of year | 180,987 | 91,391 | 220,372 |
Supplemental disclosures of cash flow data: | |||
Cash paid for interest | 3,744 | 4,073 | 2,324 |
Cash paid for income taxes | 1,033 | 31 | 293 |
Non-cash investing and financing activities: | |||
Equipment purchased and unpaid at period-end | 12,332 | 13,871 | 8,114 |
Capitalization of leasehold improvement through non-cash lease incentive | 109 | 5,121 | 0 |
Acquisition and related transaction costs accrued at period-end | 0 | 0 | 586 |
Stock-based compensation included in capitalized software development costs | 1,711 | 0 | 0 |
Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Consolidated Balance Sheets - Beginning of Period and End of Period: | |||
Cash and cash equivalents | 180,520 | 90,878 | 220,372 |
Restricted cash in other assets | 467 | 513 | 0 |
Total cash, cash equivalents and restricted cash | $ 180,987 | $ 91,391 | $ 220,372 |
Description of Business and Sum
Description of Business and Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Description of Business and Summary of Significant Accounting Policies | Description of Business and Summary of Significant Accounting Policies Five9, Inc. and its wholly-owned subsidiaries (the “Company”) is a provider of cloud software for contact centers. The Company was incorporated in Delaware in 2001 and is headquartered in San Ramon, California. The Company has offices in Europe, Asia and Australia, which primarily provide research, development, sales, marketing, and client support services. Termination of Proposed Merger with Zoom On July 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Zoom Video Communications, Inc., a Delaware corporation (“Zoom”), and Summer Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Zoom (“Merger Sub”). On September 30, 2021, at a special meeting of the Company’s stockholders, a vote to approve the Merger was unsuccessful and immediately following the special meeting the Company and Zoom mutually agreed to terminate the Merger Agreement. The Company incurred approximately $7.6 million in transaction costs related to the Merger recorded in general and administrative expense in its consolidated statements of operations and comprehensive loss. Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation. The consolidated statement of cash flows for the year ended December 31, 2021 included in this Annual Report differs from the consolidated statement of cash flows for the year ended December 31, 2021 included in the Form 10-K for the year ended December 31, 2021 due to the changes in restricted cash, which was previously presented within operating activities and is now included within the beginning and ending cash, cash equivalents and restricted cash balances. Use of Estimates The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The significant estimates made by management affect revenue and related reserves, as well as the fair value of liabilities assumed through business combinations. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Foreign Currency The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. For these subsidiaries, the monetary assets and liabilities resulting from foreign currency transactions are adjusted to reflect the exchange rate as of the balance sheet date. Foreign currency transaction gains and losses were not significant in any period and are reported in “Other (expense) income, net” in the consolidated statements of operations and comprehensive loss. Cash and Cash Equivalents The Company’s cash and cash equivalents consist of highly liquid investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents consist of investments in money market funds and U.S. treasury securities. Marketable Investments The Company’s marketable investments consist of U.S. agency securities and government sponsored securities, U.S. treasury securities, certificates of deposit, municipal bonds, corporate bonds and commercial paper. The Company determines the appropriate classification of its investments in marketable investments at the time of purchase and re-evaluates such designation at each balance sheet date. The Company’s marketable investments have been classified and accounted for as available-for-sale. Marketable investments are carried at fair value. Concentration Risks Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at three large reputable financial institutions. Total cash and cash equivalents in excess of insured limits were $178.6 million and $89.2 million as of December 31, 2022 and 2021, respectively. The Company has not experienced any losses in such accounts. As of December 31, 2022 and 2021, no single client represented more than 10% of accounts receivable. For the years ended December 31, 2022, 2021 and 2020, no single client represented more than 10% of revenue. Allowance for Doubtful Accounts The Company uses an expected credit loss model, which requires it to consider historical loss rates and expectations of forward-looking losses to estimate its allowance for doubtful accounts on its trade accounts receivables, unbilled accounts receivables and contract assets. The following table presents the changes in the allowance for doubtful accounts (in thousands): Year Ended December 31, 2022 2021 Balance, beginning of period $ 220 $ 127 Add: bad debt expense 1,105 808 Less: write-offs, net of recoveries (1,063) (715) Balance, end of period $ 262 $ 220 Property and Equipment, Net Property and equipment is stated at cost less accumulated depreciation and amortization, and is depreciated using the straight-line method over the estimated useful lives of the assets as follows: Asset Category Estimated Useful Lives Computer and network equipment 3 to 5 years Computer software 3 years Internal-use software and development costs 1 to 5 years Furniture and fixtures 7 years Leasehold improvements Shorter of useful life or lease term The Company capitalizes certain qualifying costs incurred during the development stage of internal-use software. Costs related to preliminary project activities and post-implementation activities are expensed in research and development as incurred. Preliminary project activities include conceptual formulation, evaluation and final selection of alternatives, planning, proof of concept and requirement analysis of the selected alternative. The post-implementation stage begins when the internal-use software is ready for its intended use, and includes all internal and external training and application maintenance activities. Capitalized internal-use software costs are included within property and equipment, net on the consolidated balance sheets, and are amortized over the estimated useful life of the software, which is three years. The related amortization expense is recognized in cost of revenue. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized. The Company evaluates the recoverability of property and equipment for possible impairment whenever events or circumstances indicate that the carrying amount of such assets or asset groups may not be recoverable. Recoverability of these assets is measured by a comparison of the carrying amounts to the future undiscounted cash flows the assets or asset groups are expected to generate. If such evaluation indicates that the carrying amount of the assets or asset groups is not recoverable, the carrying amount of such assets or asset groups is reduced to fair value. No impairment losses have been recognized in any of the periods presented. Business Combinations The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed as of the acquisition date. The Company’s estimates are inherently uncertain and subject to change. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to its consolidated statements of operations and comprehensive loss. Goodwill and Intangible Assets The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value. The Company performs testing for impairment of goodwill in its fourth quarter, or as events occur or circumstances change that would more likely than not reduce the fair value of the Company’s single reporting unit below its carrying amount. A qualitative assessment is first made to determine whether it is necessary to perform the quantitative goodwill impairment test. This initial qualitative assessment includes, among other things, consideration of: (i) market capitalization of the Company; (ii) past, current and projected future earnings and equity; (iii) recent trends and market conditions; and (iv) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this initial qualitative assessment indicates that it is more likely than not that impairment exists, a second quantitative assessment will be performed, involving a comparison between the estimated fair values of the Company’s single reporting unit with its respective carrying amount including goodwill. If the carrying value exceeds estimated fair value, an impairment charge is recorded for the excess. Intangible assets, consisting of acquired developed technology, domain names and customer relationships, are carried at cost less accumulated amortization. All intangible assets have been determined to have definite lives and are amortized on a straight-line basis over their estimated remaining economic lives, ranging from three Revenue Recognition Revenue is recognized when control of the promised services is transferred to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company generates all of its revenue from contracts with customers. In contracts with multiple performance obligations, it identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the contract at contract inception. Performance obligations that are not distinct at contract inception are combined. The Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation. The Company then looks to how services are transferred to the customer in order to determine the timing of revenue recognition. Most services provided under the Company’s agreements result in the transfer of control over time. The Company’s revenue consists of subscription services and related usage as well as professional services. The Company charges clients subscription fees, usually billed on a monthly basis, for access to the Company’s VCC solution. The subscription fees are primarily based on the number of agent seats, as well as the specific VCC functionalities and applications deployed by the client. Agent seats are defined as the maximum number of named agents allowed to concurrently access the VCC cloud platform. Clients typically have more named agents than agent seats. Multiple named agents may use an agent seat, though not simultaneously. Substantially all of the Company’s clients purchase both subscriptions and related telephony usage. A small percentage of the Company’s clients subscribe to its platform but purchase telephony usage directly from a wholesale telecommunications service provider. The Company does not sell telephony usage on a stand-alone basis to any client. The related usage fees are generally based on the volume of minutes used for inbound and outbound client interactions. Revenue generated from telephony usage is presented in revenue and cost of sales on a gross basis, as the Company is the party that controls the service and is responsible for fulfilling the promise to provide the call service by diverting the calls to selected carriers. The Company also offers bundled plans, generally for smaller deployments, whereby the client is charged a single monthly fixed fee per agent seat that includes both subscription and unlimited usage in the contiguous 48 states and, in some cases, Canada. Professional services revenue is derived primarily from VCC implementations, including application configuration, system integration, optimization, education and training services. Clients are not permitted to take possession of the Company’s software. The Company offers monthly, annual and multiple-year contracts to its clients, generally with 30 days’ notice required for reductions in the number of agent seats. Increases in the number of agent seats can be provisioned almost immediately. The Company’s clients, therefore, are able to adjust the number of agent seats used to meet their changing contact center needs. The Company’s larger clients typically choose annual contracts, which generally include an implementation and ramp period of several months. Fixed subscription fees, including bundled plans, are generally billed monthly in advance, while related usage fees are billed in arrears. Support activities include technical assistance for the Company’s solution and upgrades and enhancements to the VCC cloud platform on a when-and-if-available basis, which are not billed separately. The Company generally requires advance deposits from its clients based on estimated usage when such usage is not billed as part of a bundled plan. Any unused portion of the deposit is refundable to the client upon termination of the arrangement, provided all amounts due have been paid. All fees, except usage deposits, are non-refundable. Professional services are primarily billed on a fixed-fee basis. Revenue for professional services is recognized over time, as services are performed. The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments resulting in estimated variable consideration that is included in the transaction fee. This is done to the extent that it is probable, in the Company’s judgment, that a significant reversal in the amount of cumulative revenue recognized under the contract will not occur. The Company estimates the variable consideration in order to allocate the overall transaction fee on a relative stand-alone selling price basis to its multiple performance obligations. When services are included in the contract with the customer and are not sold at their stand-alone selling price, the Company is required to estimate the number of seats the customer will use, especially during the initial ramp period of the contract, during which the Company bills under an ‘actual usage’ model for subscription-related services. To date, variable consideration has not had a material impact on the allocation of transaction fees to multiple performance obligations. The Company recognizes revenue on fixed fee professional services performance obligations based on the proportion of labor hours expended compared to the total hours expected to complete the related performance obligation. The determination of the total labor hours expected to complete the performance obligations involves judgment, which influences the initial stand-alone selling price estimate as well as the timing of professional services revenue recognition, although this is typically resolved in a short time frame. When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company assesses collection based on a number of factors, including past transaction history and the creditworthiness of the client. The Company maintains a revenue reserve for potential credits to be issued in accordance with service level agreements or for other revenue adjustments. Deferred Revenue Deferred revenue consists of billings or payments received from clients for subscription services, usage and professional services in advance of revenue recognition and is recognized in accordance with the Company’s revenue recognition policy discussed above. The Company generally invoices its clients monthly in advance for subscription services. Accordingly, the deferred revenue balance does not represent the total contract value of sales arrangements. Cost of Revenue Cost of revenue consists primarily of personnel costs, including stock-based compensation, fees that the Company pays to telecommunications providers for usage, USF contributions and other regulatory costs, depreciation and related expenses of servers and equipment, costs to build out and maintain co-location data centers, costs of public cloud-based data centers, allocated office and facility costs, amortization of acquired technology and amortization of internal-use software costs. Personnel costs include those associated with support of the Company’s solution, clients and data center operations, as well as with providing professional services. Data center costs include costs for servers and equipment to build out and setup, as well as co-location fees for the right to place the Company’s servers in data centers owned by third parties. Research and Development Research and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s solution, as well as quality assurance, testing, product management and allocated overhead. Research and development costs are expensed as incurred except for internal use software development costs that qualify for capitalization. The Company reviews development costs incurred for internal-use software in the application development stage and assesses costs for capitalization. Advertising Costs The Company primarily advertises its services through the internet and in conjunction with partners. Advertising costs are expensed as incurred and were $28.1 million, $20.8 million and $15.6 million for the years ended December 31, 2022, 2021 and 2020, respectively. Commissions Commissions consist of variable compensation earned by sales personnel and referral fees the Company pays to third parties. The Company defers all incremental commission costs to obtain the contract, and amortizes these costs over a period of benefit determined to be five years. Commission expense was $47.3 million, $31.1 million and $21.9 million for the years ended December 31, 2022, 2021 and 2020, respectively. Stock-Based Compensation All stock-based compensation granted to employees and non-employee directors is measured at the grant date fair value of the award. The Company estimates the fair value of stock options under the Company’s Equity Incentive Plans and purchase rights under the Company’s 2014 Employee Stock Purchase Plan (“2014 ESPP Plan” or “ESPP”) using the Black-Scholes option-pricing model. The fair value of restricted stock units (“RSUs”), including performance-based restricted stock units (“PRSUs”) subject to performance conditions, is equal to the fair value of the Company’s common stock on the date of grant. The fair value of PRSUs subject to market conditions are determined using a Monte Carlo Simulation model. Compensation expense is recognized net of actual forfeitures using the straight-line method over the service period, which is generally the vesting period. Income Taxes The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. The Company records a valuation allowance to reduce its deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. As of December 31, 2022, and 2021, the Company recorded a full valuation allowance against the U.S. net deferred tax assets because of its history of operating losses in the United States. As of December 31, 2022 and 2021, the Company recognized a net deferred tax asset balance of $3.8 million and $6.9 million, respectively, related to its operations in the UK and Australia. The Company classifies interest and penalties on unrecognized tax benefits as income tax expense. Comprehensive loss Comprehensive loss consists of net loss, and unrealized gains or losses on available-for-sale marketable investments. The Company presents comprehensive loss as part of the consolidated statements of operations. The changes in the accumulated balances of the components of other comprehensive loss were not material for the periods presented. Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period, and excludes any dilutive effects of employee stock-based awards and potential shares issuable upon conversion of the convertible senior notes. Diluted net loss per share is computed giving effect to all potentially dilutive shares of common stock, including common stock issuable upon exercise of stock options, vesting of RSUs and PRSUs, and shares of common stock issuable upon conversion of convertible senior notes. In periods of net loss, all potentially issuable shares of common stock are excluded from the diluted net loss per share computation because they are anti-dilutive. Therefore, basic and diluted net loss per share are the same for all years presented in the Company’s consolidated statements of operations and comprehensive loss. Indemnification The Company, in the ordinary course of business, enters into agreements of varying scope and terms pursuant to which it agrees to indemnify clients, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, including breach of security, services to be provided by the Company or from intellectual property infringement claims made by third parties. To date, the Company has not incurred any material costs as a result of such indemnification provisions and the Company has not accrued any liabilities related to such obligations in the consolidated financial statements as of December 31, 2022 and 2021. Segment Information The Company has determined that its Chief Executive Officer is its chief operating decision maker. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of assessing performance and making decisions on how to allocate resources. Accordingly, the Company has determined that it operates in a single reportable segment. Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows. |
Revenue
Revenue | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | Revenue Contract Balances The following table provides information about accounts receivable, net, deferred contract acquisition costs, net, contract assets and contract liabilities from contracts with customers (in thousands): December 31, 2022 December 31, 2021 Accounts receivable, net $ 87,494 $ 83,731 Deferred contract acquisition costs, net: Current $ 47,242 $ 33,295 Non-current 114,880 84,663 Total deferred contract acquisition costs, net $ 162,122 $ 117,958 Contract assets and contract liabilities: Contract assets (included in prepaid expenses and other current assets) $ 3,401 $ 2,593 Contract liabilities (deferred revenue) 57,816 43,720 Noncurrent contract liabilities (deferred revenue) (included in other long term liabilities) 1,178 2,097 Net contract liabilities $ (55,593) $ (43,224) The Company receives payments from customers based upon billing cycles. Invoice payment terms are usually 30 days or less. Accounts receivable are recorded when the right to consideration becomes unconditional. Deferred contract acquisition costs are recorded when incurred and are amortized over an estimated customer benefit period of five years. The Company’s contract assets consist of unbilled amounts typically resulting from professional services revenue recognition when it exceeds the total amounts billed to the customer. The Company’s contract liabilities consist of advance payments and billings in excess of revenue recognized. In the year ended December 31, 2022, the Company recognized revenue of $37.7 million related to its contract liabilities at December 31, 2021. Remaining Performance Obligations As of December 31, 2022, the aggregate amount of the total transaction price allocated in contracts with original duration of greater than one year to the remaining performance obligations was $758.9 million. The Company expects to recognize revenue on approximately three-fourths of the remaining performance obligations over the next 24 months, with the balance recognized thereafter. The Company excludes amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less. Such remaining performance obligations represent unsatisfied or partially unsatisfied performance obligations. |
Investments and Fair Value Meas
Investments and Fair Value Measurements | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Investments and Fair Value Measurements | Investments and Fair Value MeasurementsMarketable Investments The Company’s marketable investments have been classified and accounted for as available-for-sale. The Company’s marketable investments as of December 31, 2022 and 2021 were as follows (in thousands): December 31, 2022 Short-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 747 $ — $ (13) $ 734 U.S. treasury securities 186,776 8 (1,382) 185,402 U.S. agency and government-sponsored securities 197,597 29 (1,660) 195,966 Commercial paper 25,386 — — 25,386 Municipal bonds 22,764 — (145) 22,619 Corporate bonds 3,658 — (22) 3,636 Total $ 436,928 $ 37 $ (3,222) $ 433,743 December 31, 2022 Long-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. agency securities $ 885 $ — $ — $ 885 Total $ 885 $ — $ — $ 885 December 31, 2021 Short-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 1,615 $ — $ — $ 1,615 U.S. treasury securities 83,237 — (24) 83,213 U.S. agency securities 159,070 — (65) 159,005 Commercial paper 47,555 — — 47,555 Municipal bonds 75,337 — (96) 75,241 Corporate bonds 12,355 2 (6) 12,351 Total $ 379,169 $ 2 $ (191) $ 378,980 December 31, 2021 Long-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 746 $ — $ (2) $ 744 U.S. treasury securities 63,566 — (251) 63,315 U.S. agency securities 63,960 — (254) 63,706 Municipal bonds 18,655 — (64) 18,591 Corporate bonds 1,026 — (5) 1,021 Total $ 147,953 $ — $ (576) $ 147,377 The following table presents the gross unrealized losses and the fair value for those marketable investments that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands): December 31, 2022 December 31, 2021 Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Certificates of deposit $ (13) $ 734 $ (2) $ 2,010 U.S. treasury securities (1,382) 126,534 (275) 140,527 U.S. agency securities (1,660) 172,458 (320) 222,710 Municipal bonds (145) 12,623 (160) 87,184 Corporate bonds (22) 3,636 (10) 9,428 Total $ (3,222) $ 315,985 $ (767) $ 461,859 Although the Company had certain available-for-sale debt securities in an unrealized loss position as of December 31, 2022, no impairment loss was recorded since it did not intend to sell them, did not anticipate a need to sell them, and the decline in fair value was not due to any credit-related factors. Fair Value Measurements The Company carries cash equivalents and marketable investments at fair value. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations or alternative pricing sources. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded. The following tables set forth the Company’s assets measured at fair value by level within the fair value hierarchy (in thousands): December 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents Money market funds $ 37,560 $ — $ — $ 37,560 U.S. treasury securities 19,700 — — 19,700 Total cash equivalents $ 57,260 $ — $ — $ 57,260 Marketable investments (short and long-term) Certificates of deposit $ — $ 734 $ — $ 734 U.S. treasury securities 185,402 — — 185,402 U.S. agency and government sponsored securities — 196,851 — 196,851 Commercial paper — 25,386 — 25,386 Municipal bonds — 22,619 — 22,619 Corporate bonds — 3,636 — 3,636 Total marketable investments $ 185,402 $ 249,226 $ — $ 434,628 December 31, 2021 Level 1 Level 2 Level 3 Total Assets Cash equivalents Money market funds $ 31,380 $ — $ — $ 31,380 Certificates of deposit — 747 — 747 Total cash equivalents $ 31,380 $ 747 $ — $ 32,127 Marketable investments (short and long-term) Certificates of deposit $ — $ 2,359 $ — $ 2,359 U.S. Treasury 146,528 — — 146,528 U.S. agency and government sponsored securities — 222,711 — 222,711 Commercial paper — 47,555 — 47,555 Municipal bonds — 93,832 — 93,832 Corporate bonds — 13,372 — 13,372 Total marketable investments $ 146,528 $ 379,829 $ — $ 526,357 Liabilities Contingent consideration $ — $ — $ 23,740 $ 23,740 As of December 31, 2022 and 2021, the estimated fair value of the Company’s outstanding 2023 convertible senior notes was $0.3 million and $114.9 million, respectively. As of December 31, 2022 and 2021, the estimated fair value of the Company's outstanding 2025 convertible senior notes was $687.1 million and $917.3 million, respectively. The fair values were determined based on the quoted price of the convertible senior notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 6 for further information on the Company’s convertible senior notes. As part of the agreement to acquire Inference Solutions Inc. (“Inference”) in November 2020, the Company was obligated to pay contingent earn out consideration of up to $24.0 million based upon achievement of certain milestones and relative thresholds during the earn out measurement period which ended on December 31, 2021. The fair value of the contingent consideration arrangement was classified within Level 3 and was determined using a probability-based scenario analysis approach. The resulting probability-weighted contingent consideration amounts were discounted based on the Company’s estimated cost of debt. During 2022, the Company concluded and paid the final contingent consideration amount of $24.0 million. A reconciliation of the beginning and ending balance for contingent consideration consisted of the following (in thousands): Contingent Consideration Balance, December 31. 2020 $ 18,100 Change in fair value of contingent consideration 5,640 Balance, December 31, 2021 23,740 Change in fair value of contingent consideration 260 Less: Payment (24,000) Balance, December 31, 2022 $ — In February 2022, the Company made a $2.0 million equity investment in a privately-held company that it does not have the ability to exercise significant influence over. The Company elected the measurement alternative for an equity security without a readily determinable fair value. Accordingly, this investment will be accounted for at its cost minus impairment, if any, and is classified within Level 3. If the Company identifies observable price changes in orderly transactions for such investment or a similar investment, it will measure the investment at fair value as of the date that the observable transaction or events occurred. The Company concluded that there was no indicator of impairment of this investment as of December 31, 2022. Except for the $2.0 million equity investment and contingent consideration described above, there were no assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2022 and 2021. The fair value of the Company’s other financial instruments’, including accounts receivable, accounts payable and other current liabilities, approximate their carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s operating leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company. |
Financial Statement Components
Financial Statement Components | 12 Months Ended |
Dec. 31, 2022 | |
Financial Statement Components [Abstract] | |
Financial Statement Components | Financial Statement Components Cash and cash equivalents consisted of the following (in thousands): December 31, 2022 2021 Cash $ 123,260 $ 58,751 Certificates of deposit — 747 Money market funds 37,560 31,380 U.S. Treasury 19,700 — Total cash and cash equivalents $ 180,520 $ 90,878 Accounts receivable, net consisted of the following (in thousands): December 31, 2022 2021 Trade accounts receivable $ 77,621 $ 75,970 Unbilled trade accounts receivable, net of advance client deposits 10,135 7,981 Allowance for doubtful accounts (262) (220) Accounts receivable, net $ 87,494 $ 83,731 Prepaid expenses and other current assets consisted of the following (in thousands): December 31, 2022 2021 Prepaid expenses $ 17,151 $ 21,306 Other current assets 9,159 6,443 Contract assets 3,401 2,593 Prepaid expenses and other current assets $ 29,711 $ 30,342 Property and equipment, net consisted of the following (in thousands): December 31, 2022 2021 Computer and network equipment $ 148,789 $ 116,701 Computer software 50,955 44,268 Internal-use software development costs 6,111 500 Furniture and fixtures 3,326 3,953 Leasehold improvements 6,574 5,914 Property and equipment 215,755 171,336 Accumulated depreciation and amortization (114,534) (93,551) Property and equipment, net $ 101,221 $ 77,785 Depreciation and amortization expense associated with property and equipment was $33.0 million, $26.9 million and $18.2 million for the years ended December 31, 2022, 2021 and 2020, respectively. Property and equipment capitalized under finance lease obligations consists primarily of computer and network equipment and was as follows (in thousands): December 31, 2022 2021 Gross $ 36,282 $ 42,541 Less: accumulated depreciation and amortization (36,203) (41,689) Total $ 79 $ 852 Other assets consisted of the following (in thousands): December 31, 2022 2021 Other assets $ 5,081 $ 4,964 Equity investment in a privately-held company 2,000 — Deferred tax assets 3,976 6,907 Other assets $ 11,057 $ 11,871 Accrued and other current liabilities consisted of the following (in thousands): December 31, 2022 2021 Accrued expenses $ 19,343 $ 20,108 Accrued compensation and benefits 33,749 34,729 Contingent consideration — 23,740 Accrued and other current liabilities $ 53,092 $ 78,577 Other long-term liabilities consisted of the following (in thousands): December 31, 2022 2021 Deferred revenue $ 1,178 $ 2,097 Deferred tax liabilities 157 — Other long-term liabilities 1,745 5,574 Other long-term liabilities $ 3,080 $ 7,671 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill There was no activity in the Company's goodwill balance during the years ended December 31, 2022 and 2021. During the fourth quarter of 2022, the Company completed its annual goodwill impairment test. Based on its assessment of the qualitative factors, the Company’s management concluded that the fair value of the Company’s goodwill was more likely than not greater than its carrying amount as of December 31, 2022. As such, it was not necessary to perform the quantitative goodwill impairment test. Subsequent to the 2022 annual impairment test, the Company believes there have been no significant events or circumstances negatively affecting the valuation of goodwill. As of December 31, 2022 and 2021, there was no impairment to the carrying value of the Company’s goodwill. Intangible Assets The following table summarizes the activity in the Company's intangible asset balances during the years ended December 31, 2022 and 2021 (in thousands): Intangible Assets Beginning of the period, January 1, 2021 $ 51,684 Amortization (11,787) End of the period, December 31, 2021 39,897 Amortization (11,705) End of the period, December 31, 2022 $ 28,192 The components of intangible assets were as follows (in thousands): December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Net Weighted Average Remaining Amortization Period (Years) Gross Accumulated Net Weighted Average Remaining Amortization Period (Years) Developed technology $ 56,214 $ (28,881) $ 27,333 3.2 $ 56,214 $ (17,821) $ 38,393 4.0 Acquired workforce 470 (470) — 0.0 470 (334) 136 0.9 Customer relationships 1,600 (741) 859 2.7 1,600 (421) 1,179 3.7 Trademarks 500 (500) — 0.0 500 (311) 189 0.9 Total $ 58,784 $ (30,592) $ 28,192 3.2 $ 58,784 $ (18,887) $ 39,897 4.0 Amortization expense related to intangible assets was $11.7 million, $11.8 million and $6.8 million for the years ended December 31, 2022, 2021 and 2020, respectively. As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 $ 10,870 2024 7,527 2025 5,595 2026 4,200 2027 — Thereafter — Total $ 28,192 Intangible assets are reviewed for impairment whenever events or changes in circumstances indicate an asset’s carrying value may not be recoverable. The Company concluded that there was no indicators of impairment of its intangible assets as of December 31, 2022 and 2021. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | Debt 2025 Convertible Senior Notes and Related Capped Call Transactions In May and June 2020, the Company issued $747.5 million aggregate principal amount of 2025 convertible senior notes in a private offering, which aggregate principal amount included the exercise in full of the initial purchasers’ option to purchase up to an additional $97.5 million principal amount of the 2025 convertible senior notes. The 2025 convertible senior notes mature on June 1, 2025 and bear interest at a fixed rate of 0.500% per annum, payable semiannually in arrears on June 1 and December 1 of each year, beginning on December 1, 2020. The total net proceeds from the issuance of the 2025 convertible senior notes, after deducting initial purchasers' discounts and commissions and estimated debt issuance costs, were approximately $728.8 million. Each $1,000 principal amount of the 2025 convertible senior notes is initially convertible into 7.4437 shares of the Company’s common stock (the “2025 Conversion Option”), which is equivalent to an initial conversion price of approximately $134.34 per share of common stock, subject to adjustment upon the occurrence of specified events. The initial conversion price represents a premium of approximately 30% to the $103.34 per share closing price of the Company’s common stock on The Nasdaq Global Market on May 21, 2020. The 2025 convertible senior notes are convertible, in multiples of $1,000 principal amount, at the option of the holders prior to the close of business on the business day immediately preceding March 1, 2025, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “2025 Measurement Period”) in which the trading price (as defined in the 2025 Indenture governing the 2025 convertible senior notes) per $1,000 principal amount of the 2025 convertible senior notes for each trading day of the 2025 Measurement Period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate in effect on each such trading day; (3) if the Company calls any or all of the 2025 convertible senior notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after March 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2025 convertible senior notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election. If the Company undergoes a fundamental change (as defined in the indenture governing the 2025 convertible senior notes), subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their 2025 convertible senior notes, in principal amounts of $1,000 or a multiple thereof, at a fundamental change repurchase price equal to 100% of the principal amount of the 2025 convertible senior notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their notes in connection with such corporate event or during the relevant redemption period. There have been no changes to the initial conversion price of the 2025 convertible senior notes since issuance. The closing market price of the Company's common stock of $67.86 per share as of December 30, 2022, the last trading day during the three months ended December 31, 2022, was below $174.64 per share, which represents 130% of the initial conversion price of $134.34 per share. Additionally, the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day, December 30, 2022, was not greater than or equal to 130% of the initial conversion price. As such, during the three months ended December 31, 2022, the conditions allowing holders of the 2025 convertible senior notes to convert were not met. The 2025 convertible senior notes are therefore not convertible for the three months ending March 31, 2023. The Company may not redeem the 2025 convertible senior notes prior to June 6, 2023. The Company may redeem for cash all or any portion of the 2025 convertible senior notes, at its option, on or after June 6, 2023 and prior to March 1, 2025 if the last reported sale price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending not more than two trading days immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the 2025 convertible senior notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. No sinking fund is provided for the 2025 convertible senior notes. The 2025 convertible senior notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the 2025 convertible senior notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated (including the 2023 convertible senior notes); effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries. The net carrying amount of the 2025 convertible senior notes as of December 31, 2022 and 2021 was as follows (in thousands): December 31, 2022 December 31, 2021 Principal $ 747,500 $ 747,500 Unamortized issuance costs (9,124) (12,835) Net carrying amount $ 738,376 $ 734,665 Interest expense related to the 2025 convertible senior notes was as follows (in thousands): Year Ended December 31, 2022 December 31, 2021 December 31, 2020 Contractual interest expense $ 3,737 $ 4,007 $ 2,230 Amortization of debt discount — — 16,528 Amortization of issuance costs 3,711 3,674 1,538 Total interest expense $ 7,448 $ 7,681 $ 20,296 In connection with the issuance of the 2025 convertible senior notes, the Company entered into privately negotiated capped call transactions (the “2025 Capped Call Transactions”) with certain financial institutions. The initial cap price of the 2025 Capped Call Transactions was $206.68 per share and is subject to certain adjustments under the terms of the 2025 Capped Call Transactions. The 2025 Capped Call Transactions cover, subject to anti-dilution adjustments, approximately 5.6 million shares of the Company’s common stock. 2023 Convertible Senior Notes and Related Capped Call Transactions In May 2018, the Company issued $258.8 million aggregate principal amount of the 2023 convertible senior notes in a private offering. The 2023 convertible senior notes mature on May 1, 2023 and bear interest at a fixed rate of 0.125% per annum, payable semiannually in arrears on May 1 and November 1 of each year. The total net proceeds from the offering, after deducting initial purchasers' discounts and commissions and estimated debt issuance costs, was approximately $250.8 million. In May 2020, the Company used part of the net proceeds from the issuance of the 2025 convertible senior notes to repurchase, exchange or otherwise retire approximately $181.0 million aggregate principal amount of the 2023 convertible senior notes in privately-negotiated transactions for aggregate consideration of $449.6 million, consisting of $181.0 million in cash and 2,723,581 shares of the Company’s common stock (the "2023 Note Repurchase Transactions"). As of December 31, 2022, after giving effect to the 2023 Note Repurchase Transactions and other settlements upon conversion requests, approximately $0.2 million aggregate principal amount of 2023 convertible senior notes remained outstanding. The 2023 Note Repurchase Transactions were accounted for as a debt extinguishment. Pursuant to ASC Subtopic 470-20 under existing accounting rules prior to ASU 2020-06 adoption, total consideration for the 2023 Note Repurchase Transactions was separated into liability and equity components by estimating the fair value of a similar liability without a conversion option and assigning the residual value to the equity component. The gain or loss on extinguishment of the debt was subsequently determined by comparing the repurchase consideration allocated to the liability component to the sum of the carrying value of the liability component, net of the proportionate amounts of unamortized debt discount and the remaining unamortized debt issuance costs. Of the $449.6 million in aggregate consideration paid by the Company in connection with the 2023 Note Repurchase Transactions, $155.8 million and $293.8 million were allocated to the debt and equity components, respectively, using an effective interest rate of 5.32% to determine the fair value of the liability component. This interest rate was based on the income and market-based approaches used to determine the effective interest rate of the 2023 convertible senior notes, adjusted for the remaining term of the 2023 convertible senior notes. As of the settlement of the 2023 Note Repurchase Transactions, the carrying value of the 2023 convertible senior notes subject to the 2023 Note Repurchase Transactions, net of unamortized debt discount and issuance costs, was $150.4 million. The Company also incurred approximately $0.5 million in third party transaction costs related to the 2023 Note Repurchase Transactions. These costs were allocated to the liability and equity components in proportion to the allocation of consideration transferred at settlement and accounted for as debt extinguishment costs and equity reacquisition costs, respectively. The 2023 Note Repurchase Transactions resulted in a $5.8 million loss on early debt extinguishment in the second quarter of fiscal 2020, of which $2.7 million consisted of unamortized debt issuance costs. Each $1,000 principal amount of the 2023 convertible senior notes was initially convertible into 24.4978 shares of the Company’s common stock (the “2023 Conversion Option”), which is equivalent to an initial conversion price of approximately $40.82 per share of common stock, subject to adjustment upon the occurrence of specified events. The 2023 convertible senior notes were convertible, in multiples of $1,000 principal amount, at the option of the holders at any time prior to the close of business on the business day immediately preceding November 1, 2022, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ended on September 30, 2018 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “2023 Measurement Period”) in which the trading price (as defined in the indenture governing the 2023 convertible senior notes) per $1,000 principal amount of the 2023 convertible senior notes for each trading day of the 2023 Measurement Period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate in effect on each such trading day; (3) if the Company calls any or all of the 2023 convertible senior notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after November 1, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their 2023 convertible senior notes, in multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election. If the Company undergoes a fundamental change (as defined in the indenture governing the 2023 convertible senior notes), subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their 2023 convertible senior notes, in principal amounts of $1,000 or a multiple thereof, at a fundamental change repurchase price equal to 100% of the principal amount of the 2023 convertible senior notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their 2023 convertible senior notes in connection with such corporate event or during the relevant redemption period. There have been no changes to the initial conversion price of the 2023 convertible senior notes since issuance. During each of the quarters from the third quarter of 2019 through the third quarter of 2022, one of the triggers for convertibility of the 2023 convertible senior notes was triggered as the last reported sale price of the Company’s common stock was greater than $53.07 per share, which represents 130% of the initial conversion price of $40.82 per share, for at least 20 trading days in the period of 30 consecutive trading days ended on, and including, the last trading day of the quarter for each quarter of 2020, 2021 and for the first three quarters of 2022. As a result, the 2023 convertible senior notes were convertible, in multiples of $1,000 principal amount, at the option of the 2023 convertible senior note holders between October 1, 2019 to October 31, 2022. The 2023 convertible senior notes continue to be convertible from November 1, 2022 until the close of business on the second scheduled trading day immediately preceding the maturity date. During 2021, the Company paid $24.7 million in cash and issued 453,943 shares of its common stock to settle aggregate principal amount of $24.6 million of its 2023 convertible senior notes. During 2022, the Company paid $34.1 million in cash and issued 573,633 shares of its common stock to settle aggregate principal amount of $34.1 million of its 2023 convertible senior notes. As of December 31, 2022, approximately $0.2 million aggregate principal amount of the 2023 convertible senior notes remained outstanding. The conversions that occurred prior to January 1, 2021 resulted in a $1.2 million loss on early debt extinguishment. The conversions that occurred during 2021 and 2022 were subject to ASU 2020-06 and such conversions were accounted for as contractual conversions, which did not result in any gain or loss upon their settlement. During 2021, the Company received 68,905 shares from the partial unwind of capped calls resulting from the settlement of its 2023 convertible senior notes. During 2022, the Company received an additional 119,492 shares from the partial unwind of capped calls resulting from the settlement of its 2023 convertible senior notes. The receipt of the 68,905 and 119,492 shares reduced the number of shares of common stock outstanding. The 2023 convertible senior notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of payment to the 2023 convertible senior notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated (including the 2025 convertible senior notes); effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries. The net carrying amount of the 2023 convertible senior notes as of December 31, 2022 and 2021 was as follows (in thousands): December 31, 2022 December 31, 2021 Principal $ 169 $ 34,225 Unamortized issuance costs — (291) Net carrying amount $ 169 $ 33,934 Interest expense related to the 2023 convertible senior notes was as follows (in thousands): Year Ended December 31, 2022 December 31, 2021 December 31, 2020 Contractual interest expense $ 6 $ 42 $ 184 Amortization of debt discount — — 7,006 Amortization of issuance costs 32 283 666 Total interest expense $ 38 $ 325 $ 7,856 In connection with the issuance of the 2023 convertible senior notes, the Company entered into privately negotiated capped call transactions (the “2023 Capped Call Transactions”) with certain financial institutions. The initial cap price of the 2023 Capped Call Transactions was $62.80 per share, and is subject to certain adjustments under the terms of the 2023 Capped Call Transactions. The 2023 Capped Call Transactions cover, subject to anti-dilution adjustments, approximately 6.3 million shares of the Company’s common stock. In connection with the 2023 Note Repurchase Transactions, the Company amended the 2023 Capped Call Transactions such that the portion associated with the 2023 convertible senior notes subject to the 2023 Note Repurchase Transactions would remain outstanding notwithstanding the retirement of $181.0 million aggregate principal amount of 2023 convertible senior notes. Following such amendment, the 2023 Capped Call Transactions continue to meet the accounting criteria to be recorded in stockholders’ equity and are not accounted for as derivatives. Adoption of ASU 2020-06 On January 1, 2021, the Company elected to early adopt ASU 2020-06 based on a modified retrospective transition method. Under such transition, prior-period information was not retrospectively adjusted. Prior to the adoption of ASU 2020-06, the 2025 and 2023 convertible senior notes were separated into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The equity component was recorded in additional paid-in-capital and was not re-measured as long as it continued to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (the “Debt Discount”) was amortized to interest expense over the contractual term of the 2025 and 2023 convertible senior notes at an effective interest rate of 5.76% and 6.39%, respectively. Prior to the adoption of ASU 2020-06, the debt issuance costs related to the 2025 and 2023 convertible senior notes were allocated to the liability and equity components based on their relative values. Issuance costs attributable to the liability component were amortized to interest expense using the effective interest method over the contractual term of the 2025 and 2023 convertible senior notes. Issuance costs attributable to the equity component were netted with the equity component in additional paid-in-capital. In accounting for the 2025 and 2023 convertible senior notes after adoption of ASU 2020-06, the 2025 convertible senior notes are accounted for as a single liability, and the issuance costs related to the 2025 and 2023 convertible senior notes are being amortized to interest expense over the contractual term at an effective interest rate of 1.0% and 0.76%, respectively. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Stockholders' Equity | Stockholders’ Equity Capital Structure Common Stock The Company is authorized to issue 450,000,000 shares of common stock with a par value of $0.001 per share. As of December 31, 2022 and 2021, the Company had 71,047,179 and 68,488,337 shares of common stock issued and outstanding, respectively. During 2022 and 2021, the Company issued 573,633 and 453,943 shares, respectively, of common stock in connection with 2023 convertible senior note settlements. During 2022 and 2021, the Company also received 119,492 and 68,905 shares, respectively, from the partial unwind of capped calls resulting from the settlement of its 2023 convertible senior notes. The receipt of the 119,492 and 68,905 shares reduced the number of shares of common stock outstanding. See Note 6 for further details. Holders of the Company’s common stock are entitled to dividends, if and when declared by the board of directors. In the event of liquidation, dissolution or winding up, subject to the rights of the holders of any then outstanding shares of preferred stock, holders of common stock will be entitled to receive the assets and funds of the Company that are legally available for distribution. Preferred Stock The Company is authorized to designate and issue up to 5,000,000 shares of preferred stock with a par value of $0.001 per share in one or more series without stockholder approval and to fix the rights, preferences, privileges and restrictions thereof. As of December 31, 2022 and 2021, there were no shares of preferred stock issued and outstanding. Common Stock Reserved for Future Issuance Shares of common stock reserved for future issuance related to outstanding equity awards and employee equity incentive plans as of December 31, 2022, were as follows (in thousands): Common Stock Reserved Stock options outstanding 1,481 RSUs (including PRSUs) outstanding 3,718 Shares available for future grant under 2014 Plan 14,230 Shares available for future issuance under ESPP 3,570 Total shares of common stock reserved 22,999 Equity Incentive Plans Prior to the Company’s initial public offering (“IPO”) in April 2014, the Company granted stock options under its Amended and Restated 2004 Equity Incentive Plan, as amended (“2004 Plan”). Under the terms of the 2004 Plan, the Company had the ability to grant incentive and nonstatutory stock options. Incentive stock options could only be granted to Company employees. Nonstatutory stock options could be granted to Company employees, directors and consultants. Such options are exercisable at prices, as determined by the board of directors, generally equal to the fair value of the Company’s common stock at the date of grant. Options granted to employees generally vest over a four-year period, with an initial vesting period of 12 months for 25% of the shares, and the remaining 75% of the shares vesting monthly on a ratable basis over the remaining 36 months. Options generally expire 10 years after the grant date and are generally exercisable upon vesting. Vested options generally expire 90 days after termination of the optionee’s employment or relationship as a consultant or director, unless otherwise extended by the terms of the stock option agreement. In March 2014, the Company’s board of directors and stockholders approved the 2014 Equity Incentive Plan (“2014 Plan”) and 5,300,000 shares of common stock were authorized for issuance under the 2014 Plan. In addition, on the first day of each year beginning in 2015 and ending in 2024, the 2014 Plan provides for an annual automatic increase to the shares reserved for issuance in an amount equal to 5% of the total number of shares outstanding on December 31st of the preceding calendar year or a lesser number as determined by the Company’s board of directors. Pursuant to the automatic annual increase, 3,552,358 additional shares were reserved under the 2014 Plan on January 1, 2023. No further grants were made under the 2004 Plan once the 2014 Plan became effective on April 3, 2014. Upon the effectiveness of the 2014 Plan, all shares reserved for future issuance under the 2004 Plan became available for issuance under the 2014 Plan. Additionally, any forfeited or expired shares that would have otherwise returned to the 2004 Plan, instead return to the 2014 Plan. The 2014 Plan allows the Company to grant stock options, RSUs, restricted stock awards, performance stock awards, stock appreciation rights, performance cash awards, and other stock awards. To date, the Company has granted stock options and RSUs under the 2014 Plan. Stock options granted under the 2014 Plan are in general at a price equal to the fair market value of the common stock on the date of grant and vest over four years. The Company’s stock options expire 10 years from the date of grant. Each RSU granted under the 2014 Plan represents a right to receive one share of the Company’s common stock when the RSU vests. RSUs generally vest over one In connection with the Company’s acquisition of Inference, the Company assumed unvested stock options that had been granted under the Inference Technologies Group Inc. 2018 Equity Incentive Plan. Each of the assumed stock options are subject to substantially the same terms and conditions as applied to the assumed stock options immediately prior to the acquisition date, except that the number of shares of the Company’s common stock subject to each assumed stock option and the exercise price has been adjusted in accordance with the terms of the acquisition agreement. If these assumed stock options are cancelled, forfeited or expire unexercised, the underlying shares do not become available for future grant. As of the acquisition date, the estimated fair value of the assumed unvested options was $7.6 million, of which $0.2 million was recognized as goodwill and the balance of $7.4 million is being recognized as stock-based compensation expense over the remaining service period of the assumed unvested stock options. Stock Options A summary of the Company’s stock option activity during the year ended December 31, 2022 is as follows (in thousands, except years and per share data): Number of Shares Weighted Weighted Aggregate Intrinsic Value (1) Outstanding as of December 31, 2021 1,982 $ 38.65 Options granted 81 110.05 Options exercised (531) 16.06 Options forfeited or expired (51) 122.88 Outstanding as of December 31, 2022 1,481 47.75 4.6 $ 51,226 Vested and expected to vest as of December 31, 2022 1,481 47.75 4.6 51,226 Exercisable as of December 31, 2022 1,263 35.60 4.0 50,583 (1) The aggregate intrinsic value amounts are computed based on the difference between the exercise price of the stock options and the fair market value of the Company’s common stock of $67.86 per share as of December 30, 2022 for all in-the-money stock options outstanding. Following is additional information pertaining to the Company’s stock option activity (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Weighted average grant date fair value per share of options granted, excluding assumed stock options $ 50.44 $ 78.72 $ 38.80 Weighted average grant date fair value per share of assumed stock options — — 125.96 Intrinsic value of options exercised (1) 45,698 59,762 47,529 Total fair value of options vested during the period 11,421 12,760 7,846 Cash received from options exercised 8,522 7,402 11,656 (1) Intrinsic value of options exercised is the difference between the fair market value of the Company’s common stock at the time of exercise and the exercise price paid. Restricted Stock Units (including Performance-Based Restricted Stock Units) A summary of RSU activity (including PRSUs) during the year ended December 31, 2022 is as follows (in thousands, except years and per share data): Number of Shares Weighted Average Grant Date Fair Value Per Share Outstanding as of December 31, 2021 2,560 $ 125.65 RSUs granted (1) 2,912 90.51 RSUs vested and released (1,383) 112.18 RSUs forfeited or cancelled (371) 121.48 Outstanding as of December 31, 2022 3,718 103.55 (1) Includes 0.4 million PRSUs granted during 2022. Performance-Based Restricted Stock Units In 2022, the Company granted 0.3 million PRSUs subject to market and service conditions (“market-based PRSUs”) and with a weighted average grant date fair value of $30.6 million as part of its annual grant of equity incentive awards to certain executives and in connection with the appointment of Michael Burkland as the Company’s new Chief Executive Officer. The amount that may be earned pursuant to the PRSUs ranges from 0% to 200% of the target number based on the Company’s relative total shareholder return (“RTSR”) performance as compared to the companies in the S&P Software and Services Select Index during three one one one one one Carlo Simulation model based upon assumptions presented below. The Company recognizes the fair value of the PRSUs ratably over their requisite service period. In 2022, the Company granted 0.1 million shares of PRSUs subject to revenue-based performance and service conditions (“revenue-based PRSUs”), with a grant date fair value of $6.6 million. The amount of revenue-based PRSUs that may be earned will be determined based on achievement of two quarterly revenue goals. One third of the revenue-based PRSUs may be earned based on achievement of the first revenue target and, if achieved, will vest in four quarterly installments, with the first installment occurring on the date such achievement is certified, subject to the executive's continuous service through the applicable vesting dates. Two thirds of the revenue-based PRSUs may be earned based on achievement of the second revenue target and, if achieved, will vest in eight quarterly installments, with the first installment occurring on the date such achievement is certified, subject to the executive's continuous service through the applicable vesting dates. The revenue-based PRSUs are otherwise on the Company's standard award terms from its market-based PRSUs. The Company concluded that the first revenue target was probable of achievement at December 31, 2022, thus recognized the related stock-based compensation cost through this period. The Company, however, concluded that, as of December 31, 2022, the second revenue target was not probable of achievement, thus recognized a cumulative catch-up adjustment in the fourth quarter of 2022 to reverse all previously recognized stock-based compensation cost related to this target. The Company will reassess the probability of the achievement of the performance conditions at each reporting period and a cumulative catch-up adjustment will be recorded to stock-based compensation cost for any change in the probability assessment. Following is additional information pertaining to the Company’s RSU activity (including PRSUs) (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Weighted average grant date fair value per share of RSUs granted $ 90.51 $ 177.00 $ 86.15 Total fair value of RSUs vested during the period 125,798 174,500 136,805 Employee Stock Purchase Plan In March 2014, the Company’s board of directors and stockholders adopted the 2014 ESPP and the shares authorized for issuance thereunder. The 2014 ESPP became effective on April 3, 2014. The 2014 ESPP permits eligible employees to purchase shares of the Company’s common stock through payroll deductions with up to 15% of their pre-tax earnings subject to certain Internal Revenue Code limitations. The purchase price of the shares is 85% of the lower of the fair market value of the Company’s common stock on the first day of a six month offering period, except for the initial offering period, or the relevant purchase date. In addition, no participant may purchase more than 1,500 shares of common stock in each purchase period. The number of shares of common stock originally reserved for issuance under the 2014 ESPP was 880,000 shares, which increases automatically each year, beginning on January 1, 2015 and continuing through January 1, 2024, by the lesser of (i) 1% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year; (ii) 1,000,000 shares of common stock (subject to adjustment to reflect any split or combination of its common stock); or (iii) such lesser number as determined by its board of directors. Pursuant to the automatic annual increase, 710,471 additional shares were reserved under the 2014 ESPP on January 1, 2023. During 2022 and 2021, 190,257 and 120,992 shares were purchased by employees under the 2014 ESPP at a weighted average price of $70.50 and $127.36 per share, respectively. Stock-Based Compensation Stock-based compensation expenses for the years ended December 31, 2022, 2021 and 2020 were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Cost of revenue $ 33,297 $ 17,734 $ 9,422 Research and development 44,367 29,179 14,043 Sales and marketing 59,300 35,269 20,164 General and administrative 35,543 26,623 21,118 Total stock-based compensation $ 172,507 $ 108,805 $ 64,747 As of December 31, 2022, unrecognized stock-based compensation expense by award type and their expected weighted-average recognition periods are summarized in the following table (in thousands, except years). Stock Option RSU (excluding PRSUs) PRSU ESPP Unrecognized stock-based compensation expense $ 12,085 $ 324,834 $ 24,841 $ 3,265 Weighted-average amortization period 2.2 years 2.4 years 2.5 years 0.4 years The Company recognizes stock-based compensation expense that is calculated based upon awards that have vested, reduced for actual forfeitures. All stock-based compensation for equity awards granted to employees and non-employee directors is measured based on the grant date fair value of the award. The Company values RSUs, including PRSUs subject to performance conditions, at the closing market price of its common stock on the date of grant. The Company estimates the fair value of each stock option and purchase right under the 2014 ESPP granted to employees on the date of grant using the Black-Scholes option-pricing model using the assumptions disclosed in the table below. The Company estimates the fair value of PRSUs subject to market conditions using a Monte Carlo Simulation model using the assumptions disclosed in the table below. Expected volatility is based upon the weighting of the Company’s historical volatility. Prior to 2020, expected volatility was based upon the weighting of the Company’s historical volatility and the historical volatility of a peer group of publicly traded companies. The expected term of options granted is estimated using the simplified method by taking the average of the vesting term and the contractual term of the option. The expected volatility assumption for purchase rights under the 2014 ESPP is based on the historical volatility of the Company’s common stock. The risk-free rate for the expected term of the awards is based on U.S. Treasury zero-coupon issues at the time of grant. The Company has not paid, and does not anticipate paying, cash dividends on its shares of common stock. Accordingly, the expected dividend yield is zero. The weighted average assumptions used to value stock options granted during the periods presented were as follows: Stock Options Year Ended December 31, 2022 2021 2020 (1) Expected term (years) 6.0 6.0 5.7 Volatility 46% 47% 47% Risk-free interest rate 1.8% 1.0% 0.9% Dividend yield — — — (1) The weighted average assumptions for the year ended December 31, 2020 includes assumed stock options. The weighted average assumptions, excluding the assumed stock options, were an expected term of 6.0 years, volatility of 47%, risk-free interest rate of 1.0% and dividend yield of 0%. The weighted average assumptions of the assumed stock options were an expected term of 4.3 years, volatility of 47%, risk-free interest rate of 0.3% and dividend yield of 0%. The weighted average assumptions used to value PRSUs with market conditions granted during the periods presented were as follows: PRSUs (Market Conditions) Year Ended December 31, 2022 2021 2020 Expected term (years) 3.0 — — Volatility 53% — — Risk-free interest rate 3.5% — — Dividend yield — — — The weighted average assumptions used to value purchase rights under the 2014 ESPP granted during the periods presented were as follows: ESPP Granted In November 2022 May 2022 November 2021 May 2021 November 2020 May 2020 Expected term (years) 0.5 0.5 0.5 0.5 0.5 0.5 Volatility 59% 46% 46% 49% 50% 50% Risk-free interest rate 2.1% 0.2% 0.2% 0.1% 0.1% 0.2% Dividend yield — — — — — — |
Net Loss Per Share
Net Loss Per Share | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | Net Loss Per ShareBasic net loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period, and excludes any dilutive effects of employee stock-based awards and potential shares upon conversion of the convertible senior notes. Diluted net loss per share is computed giving effect to all potentially dilutive shares of common stock, including common stock issuable upon exercise of stock options, vesting of RSUs and PRSUs, and shares of common stock issuable upon conversion of convertible senior notes. As the Company had net losses for the years ended December 31, 2022, 2021 and 2020, all potentially issuable shares of common stock were determined to be anti-dilutive. The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Net loss $ (94,650) $ (53,000) $ (42,130) Weighted-average shares used in computing basic and diluted net loss per share 69,920 67,512 64,154 Basic and diluted net loss per share $ (1.35) $ (0.79) $ (0.66) The following securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive (in thousands): December 31, 2022 2021 2020 Stock options 1,481 1,982 2,255 RSUs (including PRSUs) 3,718 2,560 2,267 Convertible senior notes (1) 5,685 6,663 910 Total 10,884 11,205 5,432 (1) The Company used the if-converted method for 2022 and 2021 due to the adoption of ASU 2020-06 and under the treasury stock method for 2020. Prior to the adoption of ASU 2020-06, the Company used the treasury stock method for calculating any potential dilutive effect of the conversion spread of its convertible senior notes. The conversion spread had a dilutive impact for the 2023 convertible senior notes during the year ended December 31, 2020 since the average market price of the Company’s common stock during the period exceeded the initial conversion price of $40.82 per share. However, the potential shares of common stock issuable upon the conversion of the 2023 convertible senior notes were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The following table presents components of loss before income taxes for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 United States $ (76,280) $ (59,856) $ (44,303) International (13,982) (4,429) (280) Loss before income taxes $ (90,262) $ (64,285) $ (44,583) Provision for (benefit from) income taxes for the periods presented consisted of (in thousands): Year Ended December 31, 2022 2021 2020 Current: U.S. federal $ — $ — $ — U.S. state 576 262 401 Foreign 724 (202) 233 Total provision for income taxes - Current 1,300 60 634 Deferred: U.S. federal — — (2,495) U.S. state — — (414) Foreign 3,088 (11,345) (178) Total provision for (benefit from) income taxes - Deferred 3,088 (11,345) (3,087) Total provision for (benefit from) income taxes $ 4,388 $ (11,285) $ (2,453) The Company recorded a deferred income tax expense during 2022 principally due to a repatriation of intellectual property from its Australian subsidiary to the U.S., where it is offset by a valuation allowance, and a decrease in available Australian net operating loss carryforwards. Income tax (benefit) expense differed from the amount computed by applying the U.S. federal statutory income tax rate of 21% to pre-tax (loss) income for the periods presented as a result of the following (in thousands): Year Ended December 31, 2022 2021 2020 U.S. federal tax at statutory rate $ (18,957) $ (13,500) $ (9,362) U.S. state income taxes 576 262 (345) Section 162(m) 3,851 7,543 6,472 Global intangible low-taxed income 4,127 — — Non-deductible expenses 78 1,361 1,944 Research and development credit (1,194) (1,181) (837) Stock-based compensation 1,722 (25,241) (23,800) Tax benefit from acquisition/reorganizations (3,852) (5,877) (2,495) Foreign taxes 6,749 (4,760) 118 Other — 20 533 Change in valuation allowance 11,288 30,088 25,319 Total provision for (benefit from) income taxes $ 4,388 $ (11,285) $ (2,453) The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities as of December 31, 2022 and 2021 related to the following (in thousands): December 31, 2022 2021 Deferred tax assets: Net operating loss and credit carryforwards $ 125,698 $ 133,433 Capitalized R&D costs 30,552 — Accrued liabilities 10,295 12,719 Allowance for doubtful accounts 1,143 712 Amortized intangibles 3,041 872 Deferred revenue 1,992 1,351 Accrued compensation 3,238 3,963 Long-term lease liabilities 12,421 13,618 Gross deferred tax assets 188,380 166,668 Valuation allowance (135,406) (121,835) Net deferred tax assets 52,974 44,833 Deferred tax liabilities: Property and equipment (2,737) (2,633) Other (556) (509) Right of use assets (10,419) (11,573) Deferred compensation - Current (35,443) (23,211) Gross deferred tax liabilities (49,155) (37,926) Net deferred taxes $ 3,819 $ 6,907 With the exception of Russia, the Company has not provided for U.S. income taxes on undistributed earnings of its foreign subsidiaries because it intends to permanently re-invest those earnings outside the United States. The Company has plans to liquidate its Russian subsidiary. As such, the Company can no longer assert an intention to permanently re-invest those earnings. The undistributed earnings of the Company’s foreign subsidiaries were immaterial as of December 31, 2022 and 2021 and no U.S. income taxes have been accrued. A valuation allowance is provided for deferred tax assets where the recoverability of the assets is uncertain. The determination to provide a valuation allowance is dependent upon the assessment of whether it is more likely than not that sufficient future taxable income will be generated to utilize the deferred tax assets. Based on the weight of the available evidence, which includes the Company’s historical operating losses, lack of taxable income and the accumulated deficit for the year ended December 31, 2022, the Company has provided a valuation allowance against its U.S. net deferred tax assets. However, the Company has recorded net foreign deferred tax assets associated with its U.K. and Australia operations totaling $3.8 million, which cannot increase its U.S. valuation allowance. The net change in the valuation allowance for the years ended December 31, 2022 and 2021 was an increase of $13.6 million and $70.7 million, respectively. The increase in the valuation allowance in the current year was primarily attributed to the new requirement to capitalize tax research and development costs under Section 174 of the Internal Revenue Code of 1986, as amended (“IRC”), offset by an increase in the Company's deferred contract costs. The requirement to capitalize under Section 174 was passed with the Tax Cuts and Jobs Act of 2017 but was not effective until tax years beginning after December 31, 2021. Domestic expenditures will be amortized over five years, while foreign expenditures are amortized over fifteen years. As of December 31, 2022, the Company had net operating loss carryforwards for federal, state and foreign income tax purposes of $456.9 million, $310.9 million and $13.5 million, respectively, available to reduce future income subject to income taxes. If not utilized, the federal and significant state net operating loss carryforwards will begin to expire in 2024 and 2028, respectively, while the foreign net operating loss carryforwards do not expire. As of December 31, 2022, the Company also had gross research credit carryforwards for federal and California state tax purposes of $10.8 million and $7.0 million, available to reduce future income subject to income taxes. A portion of the federal research credit carryforwards will continue to expire in 2023. The California state research credits do not expire. The IRC imposes restrictions on the utilization of net operating losses and credits in the event of an “ownership change” of a corporation. Accordingly, a company’s ability to use net operating losses and credits may be subject to substantial limitation as prescribed under the IRC Sections 382 and 383 and similar state provisions. Events that may cause limitations in the amount of the net operating losses and credits that the Company may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. In the event the Company has changes in ownership, net operating losses and research and development credit carryforwards, which are fully reserved by the deferred tax asset valuation allowance, could be limited and may expire unutilized. Unrecognized Tax Benefits The table below shows the changes in the gross amount of unrecognized tax benefits for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 Unrecognized benefit — beginning of period $ 7,643 $ 6,076 $ 4,471 Gross increases — current year tax positions 1,773 1,851 1,605 Gross decreases — prior year tax positions (1) — — Settlements with tax authorities — (284) — Unrecognized benefit — end of period $ 9,415 $ 7,643 $ 6,076 As of each of December 31, 2022 and 2021, the Company did not have any unrecognized tax benefits that, if recognized, would have a material impact on its effective tax rate for each such respective year. The Company recognizes interest and penalties related to uncertain tax positions as income tax expense. The Company does not anticipate its total unrecognized tax benefits as of December 31, 2022 will significantly change due to settlement of examination or the expiration of statutes of limitation during the next 12 months. The Company is currently unaware of any uncertain tax positions that could result in significant additional payments, accruals or other material deviation in this estimate over the next 12 months. The Company is subject to taxation in the United States, various states and several foreign jurisdictions. Due to the Company’s net carryover of unused operating losses, all years from 2001 forward remain subject to future examination by the U.S. federal and state tax authorities. The Company’s foreign tax returns are open to audit under the statutes of limitation of the respective foreign countries in which its subsidiaries are located. With the exception of Russia, the Company considers all undistributed earnings of its foreign subsidiaries indefinitely reinvested. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Commitments As of December 31, 2022, $747.7 million of aggregate principal of the convertible senior notes were outstanding. The 2023 convertible senior notes and the 2025 convertible senior notes are due on May 1, 2023 and June 1, 2025, respectively. See Note 6 for more information concerning the convertible senior notes. The Company had outstanding operating lease obligations of $57.9 million as of December 31, 2022. See Note 13 for further details. As of December 31, 2022, the Company also had outstanding cloud service agreement commitments totaling $41.1 million, of which $29.0 million is expected to be paid in 2023 and the remaining $12.1 million in 2024. Hosting and Telecommunication Usage Services The Company has agreements with third parties to provide co-location hosting and telecommunication usage services. The agreements require payments per month for a fixed period of time in exchange for certain guarantees of network and telecommunication availability. As of December 31, 2022, future minimum payments under these arrangements were as follows in thousands): Year Ending December 31, Hosting Services Telecommunication Usage Services 2023 $ 588 $ 7,467 2024 238 5,940 2025 4 1,304 2026 — 459 Thereafter $ — $ — Total future minimum payment $ 830 $ 15,170 Universal Services Fund Liability The Company is classified as a telecommunications service provider for regulatory purposes and is required to make contributions to the USF based on the revenue the Company receives from the resale of interstate and some international telecommunications services. In order to comply with the obligation to make direct contributions, the Company is registered with the USAC, which is charged by the FCC with administering the USF, and has been remitting the required contributions to USAC since its registration with the USAC in April 2013. The Company also made retroactive USF contributions based on its revenues for the period from 2008 to 2012. The Company, however, has an unresolved and arguably dormant dispute with the FCC regarding whether the Company is liable for USF contributions related to the period from 2003 through 2007. As of December 31, 2022, the Company had accrued $0.1 million in interest related to the disputed assessments for the period of 2003 through 2007. State and Local Taxes and Surcharges The Company, based on analysis of its activities, has determined that it is obligated to collect and remit U.S. state or local sales, use, gross receipts, excise and utility user taxes, as well as fees or surcharges as a communications service provider in certain U.S. states, municipalities or local tax jurisdictions. The Company is registered for, collecting and remitting applicable taxes where such a determination has been made. Prior to the Company’s making such determination, the Company neither collected nor remitted these taxes, fees or surcharges to applicable local, municipal or state jurisdictions. The Company continues to analyze its activities to determine if it is subject to these taxes in additional jurisdictions and based on the Company’s ongoing assessment of its U.S. state and local tax collection and remittance obligations, the Company registers for tax and regulatory purposes in such jurisdictions and commences collecting and remitting applicable state and local taxes and surcharges to these jurisdictions. As of December 31, 2022 and 2021, the Company had total accrued liabilities of $1.2 million and $1.0 million, respectively, for such contingent sales taxes and surcharges that were not being collected from its clients but may be imposed by various taxing authorities, of which $0.3 million and $0.2 million, respectively, were included in current “Sales tax liabilities” on the consolidated balance sheets, and the remaining were included in non-current “Sales tax liabilities” on the consolidated balance sheets. The Company’s estimate of the probable loss incurred under this contingency is based on its analysis of the source location of its usage-based fees and the regulations and rules in each tax jurisdiction. Legal Matters The Company is involved in various legal and regulatory matters arising in the normal course of business. In management’s opinion, resolution of these matters is not expected to have a material impact on the Company’s consolidated results of operations, cash flows, or its financial position. However, due to the uncertain nature of legal matters, an unfavorable resolution of a matter could materially affect the Company’s future consolidated results of operations, cash flows or financial position in a particular period. The Company expenses legal fees as incurred. Indemnification Agreements In the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify clients, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, including breach of security, services to be provided by the Company or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors, officers and certain employees |
Geographical Information
Geographical Information | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Geographical Information | Geographical Information The following table summarizes revenues by geographic region based on client billing address (in thousands): Year Ended December 31, 2022 2021 2020 United States $ 702,206 $ 556,385 $ 400,509 International 76,640 53,206 34,399 Total revenue $ 778,846 $ 609,591 $ 434,908 The following table summarizes total property and equipment, net in the respective locations (in thousands): December 31, 2022 2021 United States $ 92,659 $ 68,674 International 8,562 9,111 Property and equipment, net $ 101,221 $ 77,785 |
Retirement Plans
Retirement Plans | 12 Months Ended |
Dec. 31, 2022 | |
Retirement Benefits [Abstract] | |
Retirement Plans | Retirement Plans The Company has a 401(k) plan to provide tax deferred salary deductions for all eligible employees. Participants may make voluntary contributions to the 401(k) plan, limited by certain Internal Revenue Service restrictions. The Company is responsible for the administrative costs of the 401(k) plan. The Company began matching employee contributions in cash in the fourth quarter of 2019. The contribution expense for the years ended December 31, 2022 and 2021 was $2.1 million and $1.8 million, respectively. The Company complies with the requirement of maintaining a retirement plan for employees in the Philippines. This plan is a non-contributory and defined benefit plan that provides retirement to employees equal to approximately one month salary for every year of credited service for employees who attain the normal retirement age of 60 with at least five years of service. The benefits are paid in a lump sum amount upon retirement from the Company. Total defined benefit liability under this plan was $0.5 million and $0.6 million as of each of December 31, 2022 and 2021, respectively. Total retirement expense for this plan were $0.2 million, $0.2 million, and $0.1 million for the years ended December 31, 2022, 2021, and 2020, respectively. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases | Leases The Company has leases for offices, data centers and computer and networking equipment that expire at various dates through 2031. The Company’s leases have remaining terms of one three The components of lease expenses were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Operating lease cost $ 12,072 $ 10,238 $ 6,142 Finance lease cost: Amortization of right-of-use assets $ 56 $ 438 $ 748 Interest on finance lease liabilities — — 212 Total finance lease cost $ 56 $ 438 $ 960 Supplemental cash flow information related to leases was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash used in operating leases $ (11,684) $ (7,178) $ (6,531) Financing cash used in finance leases — (612) (3,715) Right of use assets obtained in exchange for lease obligations: Operating leases 5,984 50,101 5,980 Finance leases — — — Supplemental balance sheet information related to leases was as follows (in thousands): December 31, 2022 2021 Operating leases Operating lease right-of-use assets $ 44,120 $ 48,703 Operating lease liabilities: $ 10,626 $ 9,826 Operating lease liabilities — less current portion 41,389 47,088 Total operating lease liabilities $ 52,015 $ 56,914 Finance leases Property and equipment, gross $ 36,282 $ 42,541 Less: accumulated depreciation and amortization (36,203) (41,689) Property and equipment, net $ 79 $ 852 Weighted average remaining terms were as follows (in years): December 31, 2022 2021 Weighted average remaining lease term Operating leases 6.4 years 7.3 years Finance leases 0.0 years 0.0 years Weighted average discount rates were as follows: December 31, 2022 2021 Weighted average discount rate Operating leases 3.4 % 3.2 % Finance leases — % — % Maturities of lease liabilities were as follows (in thousands): Year Ending December 31, Operating Leases 2023 $ 12,246 2024 9,986 2025 7,144 2026 5,679 2027 5,718 Thereafter 17,081 Total future minimum lease payments 57,854 Less: imputed interest (5,839) Total $ 52,015 |
Leases | Leases The Company has leases for offices, data centers and computer and networking equipment that expire at various dates through 2031. The Company’s leases have remaining terms of one three The components of lease expenses were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Operating lease cost $ 12,072 $ 10,238 $ 6,142 Finance lease cost: Amortization of right-of-use assets $ 56 $ 438 $ 748 Interest on finance lease liabilities — — 212 Total finance lease cost $ 56 $ 438 $ 960 Supplemental cash flow information related to leases was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash used in operating leases $ (11,684) $ (7,178) $ (6,531) Financing cash used in finance leases — (612) (3,715) Right of use assets obtained in exchange for lease obligations: Operating leases 5,984 50,101 5,980 Finance leases — — — Supplemental balance sheet information related to leases was as follows (in thousands): December 31, 2022 2021 Operating leases Operating lease right-of-use assets $ 44,120 $ 48,703 Operating lease liabilities: $ 10,626 $ 9,826 Operating lease liabilities — less current portion 41,389 47,088 Total operating lease liabilities $ 52,015 $ 56,914 Finance leases Property and equipment, gross $ 36,282 $ 42,541 Less: accumulated depreciation and amortization (36,203) (41,689) Property and equipment, net $ 79 $ 852 Weighted average remaining terms were as follows (in years): December 31, 2022 2021 Weighted average remaining lease term Operating leases 6.4 years 7.3 years Finance leases 0.0 years 0.0 years Weighted average discount rates were as follows: December 31, 2022 2021 Weighted average discount rate Operating leases 3.4 % 3.2 % Finance leases — % — % Maturities of lease liabilities were as follows (in thousands): Year Ending December 31, Operating Leases 2023 $ 12,246 2024 9,986 2025 7,144 2026 5,679 2027 5,718 Thereafter 17,081 Total future minimum lease payments 57,854 Less: imputed interest (5,839) Total $ 52,015 |
Acquisitions
Acquisitions | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Acquisitions | Acquisitions Inference Solutions On November 18, 2020, the Company acquired all of the issued and outstanding shares of Inference for total consideration of approximately $156.7 million. The total consideration comprised of $137.0 million in cash, net of cash acquired, and $18.1 million in estimated fair value of contingent earn out consideration. The contingent earn out consideration was up to $24.0 million and was based upon achievement of certain milestones and relative thresholds during the earn out measurement period which ended on December 31, 2021. The range of amounts that the Company could pay under the contingent consideration arrangement was between $0.0 million and $24.0 million. During 2022, the Company concluded and paid the final contingent consideration amount of $24.0 million. See Note 3 for additional information regarding the contingent consideration arrangement. This acquisition, which was accounted for as a business combination, is intended to accelerate the Company’s AI position through the addition of Inference’s widely deployed IVA platform. The excess of the purchase price over identifiable intangible assets and net tangible assets in the amount of $131.0 million was allocated to goodwill, which is not deductible for tax purposes. The fair values assigned to assets acquired and liabilities assumed are based on management’s best estimates and assumptions as of the reporting date and are considered final. The following table presents the final allocation of the purchase price at the acquisition date (in thousands): Cash $ 1,394 Property and equipment acquired 124 Other assets acquired 2,238 Acquired technology 28,600 Customer relationships 1,100 Trade name and trademarks 400 Goodwill 130,976 Total assets acquired 164,832 Liabilities assumed (3,525) Deferred tax liability (4,616) Total consideration $ 156,691 Total consideration (net of cash acquired) $ 155,297 The acquired technology, customer relationships, and trade name are being amortized on a straight-line basis over their assigned useful lives of six years, five years, and two years, respectively. The Company used the income approach to estimate the fair value of intangible assets acquired. The results of operations of this acquisition are included in the accompanying consolidated statements of operations and comprehensive loss from the date of acquisition. Virtual Observer On April 1, 2020, the Company acquired all of the issued and outstanding shares of common stock of Virtual Observer, formerly Coordinated Systems, Inc., for cash consideration of approximately $32.2 million, subject to adjustment, pursuant to a stock purchase agreement by and among the Company and Robert H. Hutcheon, David R. Brower and Daniel J. McGrail, dated January 15, 2020. This acquisition, which was accounted for as a business combination, is intended to expand the Company's portfolio to include a cloud-based WFO offering as a complement to its ongoing strategic partnerships with leading WFO providers. The excess of the purchase price over identifiable intangible assets and net tangible assets in the amount of $22.6 million was allocated to goodwill, which is not deductible for tax purposes. The fair values assigned to assets acquired and liabilities assumed are based on management’s best estimates and assumptions as of the reporting date and are considered final. The following table presents the final allocation of the purchase price at the acquisition date (in thousands): Cash $ 168 Tangible assets acquired 200 Acquired technology 12,200 Customer relationships 500 Trade name and trademarks 100 Goodwill 22,646 Total assets acquired 35,814 Deferred tax liability (2,910) Liabilities assumed (682) Total $ 32,222 The acquired technology, customer relationships, and trade name and trademarks are being amortized on a straight-line basis over their estimated useful lives of five years, five years, and two years, respectively. The Company used the income approach to estimate the fair value of intangible assets acquired. |
Selected Quarterly Financial Da
Selected Quarterly Financial Data (Unaudited) | 12 Months Ended |
Dec. 31, 2022 | |
Quarterly Financial Information Disclosure [Abstract] | |
Selected Quarterly Financial Data (Unaudited) | Selected Quarterly Financial Data (Unaudited) Selected quarterly financial information for 2022 and 2021 is as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands, except per share data) Revenue $ 208,345 $ 198,342 $ 189,382 $ 182,777 $ 173,599 $ 154,328 $ 143,782 $ 137,882 Cost of revenue (1)(2) 96,294 94,111 88,229 88,867 79,764 67,137 64,395 59,803 Gross profit 112,051 104,231 101,153 93,910 93,835 87,191 79,387 78,079 Operating expenses: Research and development (1)(2) 36,865 34,113 34,992 35,824 30,448 29,680 24,648 22,121 Sales and marketing (1)(2) 65,928 67,353 64,098 64,611 53,394 49,712 46,024 44,799 General and administrative (1)(2) 22,509 24,496 23,824 24,314 21,972 26,790 22,909 22,245 Total operating expenses 125,302 125,962 122,914 124,749 105,814 106,182 93,581 89,165 Loss from operations (13,251) (21,731) (21,761) (30,839) (11,979) (18,991) (14,194) (11,086) Other (expense) income, net: Interest expense (1,887) (1,879) (1,857) (1,870) (2,024) (1,947) (2,118) (1,938) Other (expense) and interest income 2,706 982 280 845 (43) 213 (353) 175 Total other (expense) income, net 819 (897) (1,577) (1,025) (2,067) (1,734) (2,471) (1,763) Loss before income taxes (12,432) (22,628) (23,338) (31,864) (14,046) (20,725) (16,665) (12,849) Provision for (benefit from) income taxes 1,221 579 332 2,256 (10,445) (188) (135) (517) Net loss $ (13,653) $ (23,207) $ (23,670) $ (34,120) $ (3,601) $ (20,537) $ (16,530) $ (12,332) Net loss per share: Basic $ (0.19) $ (0.33) $ (0.34) $ (0.49) $ (0.05) $ (0.30) $ (0.25) $ (0.18) Diluted $ (0.19) $ (0.33) $ (0.34) $ (0.49) $ (0.05) $ (0.30) $ (0.25) $ (0.18) Shares used in computing net loss per share: Basic 70,704 70,232 69,748 68,974 68,207 67,800 67,292 66,721 Diluted 70,704 70,232 69,748 68,974 68,207 67,800 67,292 66,721 (1) Included stock-based compensation as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands) Cost of revenue $ 8,638 $ 8,329 $ 8,538 $ 7,793 $ 6,854 $ 3,994 $ 3,781 $ 3,105 Research and development 11,799 10,603 11,818 10,145 9,163 9,101 6,152 4,763 Sales and marketing 15,152 15,761 14,963 13,424 11,987 8,304 8,208 6,771 General and administrative 8,235 9,810 9,467 8,032 7,597 5,996 6,760 6,269 Total stock-based compensation $ 43,824 $ 44,503 $ 44,786 $ 39,394 $ 35,601 $ 27,395 $ 24,901 $ 20,908 (2) Included depreciation and amortization expenses as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands) Cost of revenue $ 8,803 $ 8,904 $ 8,747 $ 8,500 $ 8,301 $ 7,658 $ 7,825 $ 7,087 Research and development 768 768 804 825 948 1,004 729 596 Sales and marketing 1 1 1 1 1 1 1 1 General and administrative 1,449 1,542 2,088 1,469 1,288 1,117 1,096 1,079 Total depreciation and amortization $ 11,021 $ 11,215 $ 11,640 $ 10,795 $ 10,538 $ 9,780 $ 9,651 $ 8,763 |
Description of Business and S_2
Description of Business and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting. All intercompany transactions and balances have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The significant estimates made by management affect revenue and related reserves, as well as the fair value of liabilities assumed through business combinations. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. |
Foreign Currency | Foreign Currency The functional currency of the Company’s foreign subsidiaries is the U.S. dollar. For these subsidiaries, the monetary assets and liabilities resulting from foreign currency transactions are adjusted to reflect the exchange rate as of the balance sheet date. Foreign currency transaction gains and losses were not significant in any period and are reported in “Other (expense) income, net” in the consolidated statements of operations and comprehensive loss. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company’s cash and cash equivalents consist of highly liquid investments with maturities of three months or less at the time of purchase. The Company’s cash equivalents consist of investments in money market funds and U.S. treasury securities. |
Marketable Investments | Marketable InvestmentsThe Company’s marketable investments consist of U.S. agency securities and government sponsored securities, U.S. treasury securities, certificates of deposit, municipal bonds, corporate bonds and commercial paper. The Company determines the appropriate classification of its investments in marketable investments at the time of purchase and re-evaluates such designation at each balance sheet date. The Company’s marketable investments have been classified and accounted for as available-for-sale. Marketable investments are carried at fair value. |
Concentration Risks | Concentration RisksFinancial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at three large reputable financial institutions. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts The Company uses an expected credit loss model, which requires it to consider historical loss rates and expectations of forward-looking losses to estimate its allowance for doubtful accounts on its trade accounts receivables, unbilled accounts receivables and contract assets. |
Property and Equipment, Net | Property and Equipment, Net Property and equipment is stated at cost less accumulated depreciation and amortization, and is depreciated using the straight-line method over the estimated useful lives of the assets as follows: Asset Category Estimated Useful Lives Computer and network equipment 3 to 5 years Computer software 3 years Internal-use software and development costs 1 to 5 years Furniture and fixtures 7 years Leasehold improvements Shorter of useful life or lease term The Company capitalizes certain qualifying costs incurred during the development stage of internal-use software. Costs related to preliminary project activities and post-implementation activities are expensed in research and development as incurred. Preliminary project activities include conceptual formulation, evaluation and final selection of alternatives, planning, proof of concept and requirement analysis of the selected alternative. The post-implementation stage begins when the internal-use software is ready for its intended use, and includes all internal and external training and application maintenance activities. Capitalized internal-use software costs are included within property and equipment, net on the consolidated balance sheets, and are amortized over the estimated useful life of the software, which is three years. The related amortization expense is recognized in cost of revenue. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are removed from the consolidated balance sheet and any resulting gain or loss is reflected in the consolidated statements of operations and comprehensive loss in the period realized. |
Business Combinations | Business Combinations The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed as of the acquisition date. The Company’s estimates are inherently uncertain and subject to change. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets and liabilities assumed, with the corresponding offset to goodwill. In addition, uncertain tax positions and tax-related valuation allowances are initially established in connection with a business combination as of the acquisition date. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to its consolidated statements of operations and comprehensive loss. |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The Company records goodwill when the consideration paid in a business combination exceeds the fair value of the net tangible assets and the identified intangible assets acquired. Goodwill is not amortized, but instead is required to be tested for impairment annually and whenever events or changes in circumstances indicate that the carrying value of goodwill may exceed its fair value. The Company performs testing for impairment of goodwill in its fourth quarter, or as events occur or circumstances change that would more likely than not reduce the fair value of the Company’s single reporting unit below its carrying amount. A qualitative assessment is first made to determine whether it is necessary to perform the quantitative goodwill impairment test. This initial qualitative assessment includes, among other things, consideration of: (i) market capitalization of the Company; (ii) past, current and projected future earnings and equity; (iii) recent trends and market conditions; and (iv) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this initial qualitative assessment indicates that it is more likely than not that impairment exists, a second quantitative assessment will be performed, involving a comparison between the estimated fair values of the Company’s single reporting unit with its respective carrying amount including goodwill. If the carrying value exceeds estimated fair value, an impairment charge is recorded for the excess. three |
Revenue Recognition | Revenue Recognition Revenue is recognized when control of the promised services is transferred to customers in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company generates all of its revenue from contracts with customers. In contracts with multiple performance obligations, it identifies each performance obligation and evaluates whether the performance obligations are distinct within the context of the contract at contract inception. Performance obligations that are not distinct at contract inception are combined. The Company allocates the transaction price to each distinct performance obligation proportionately based on the estimated standalone selling price for each performance obligation. The Company then looks to how services are transferred to the customer in order to determine the timing of revenue recognition. Most services provided under the Company’s agreements result in the transfer of control over time. The Company’s revenue consists of subscription services and related usage as well as professional services. The Company charges clients subscription fees, usually billed on a monthly basis, for access to the Company’s VCC solution. The subscription fees are primarily based on the number of agent seats, as well as the specific VCC functionalities and applications deployed by the client. Agent seats are defined as the maximum number of named agents allowed to concurrently access the VCC cloud platform. Clients typically have more named agents than agent seats. Multiple named agents may use an agent seat, though not simultaneously. Substantially all of the Company’s clients purchase both subscriptions and related telephony usage. A small percentage of the Company’s clients subscribe to its platform but purchase telephony usage directly from a wholesale telecommunications service provider. The Company does not sell telephony usage on a stand-alone basis to any client. The related usage fees are generally based on the volume of minutes used for inbound and outbound client interactions. Revenue generated from telephony usage is presented in revenue and cost of sales on a gross basis, as the Company is the party that controls the service and is responsible for fulfilling the promise to provide the call service by diverting the calls to selected carriers. The Company also offers bundled plans, generally for smaller deployments, whereby the client is charged a single monthly fixed fee per agent seat that includes both subscription and unlimited usage in the contiguous 48 states and, in some cases, Canada. Professional services revenue is derived primarily from VCC implementations, including application configuration, system integration, optimization, education and training services. Clients are not permitted to take possession of the Company’s software. The Company offers monthly, annual and multiple-year contracts to its clients, generally with 30 days’ notice required for reductions in the number of agent seats. Increases in the number of agent seats can be provisioned almost immediately. The Company’s clients, therefore, are able to adjust the number of agent seats used to meet their changing contact center needs. The Company’s larger clients typically choose annual contracts, which generally include an implementation and ramp period of several months. Fixed subscription fees, including bundled plans, are generally billed monthly in advance, while related usage fees are billed in arrears. Support activities include technical assistance for the Company’s solution and upgrades and enhancements to the VCC cloud platform on a when-and-if-available basis, which are not billed separately. The Company generally requires advance deposits from its clients based on estimated usage when such usage is not billed as part of a bundled plan. Any unused portion of the deposit is refundable to the client upon termination of the arrangement, provided all amounts due have been paid. All fees, except usage deposits, are non-refundable. Professional services are primarily billed on a fixed-fee basis. Revenue for professional services is recognized over time, as services are performed. The estimation of variable consideration for each performance obligation requires the Company to make subjective judgments resulting in estimated variable consideration that is included in the transaction fee. This is done to the extent that it is probable, in the Company’s judgment, that a significant reversal in the amount of cumulative revenue recognized under the contract will not occur. The Company estimates the variable consideration in order to allocate the overall transaction fee on a relative stand-alone selling price basis to its multiple performance obligations. When services are included in the contract with the customer and are not sold at their stand-alone selling price, the Company is required to estimate the number of seats the customer will use, especially during the initial ramp period of the contract, during which the Company bills under an ‘actual usage’ model for subscription-related services. To date, variable consideration has not had a material impact on the allocation of transaction fees to multiple performance obligations. The Company recognizes revenue on fixed fee professional services performance obligations based on the proportion of labor hours expended compared to the total hours expected to complete the related performance obligation. The determination of the total labor hours expected to complete the performance obligations involves judgment, which influences the initial stand-alone selling price estimate as well as the timing of professional services revenue recognition, although this is typically resolved in a short time frame. When a contract with a customer is signed, the Company assesses whether collection of the fees under the arrangement is probable. The Company assesses collection based on a number of factors, including past transaction history and the creditworthiness of the client. The Company maintains a revenue reserve for potential credits to be issued in accordance with service level agreements or for other revenue adjustments. Deferred Revenue Deferred revenue consists of billings or payments received from clients for subscription services, usage and professional services in advance of revenue recognition and is recognized in accordance with the Company’s revenue recognition policy discussed above. The Company generally invoices its clients monthly in advance for subscription services. Accordingly, the deferred revenue balance does not represent the total contract value of sales arrangements. Cost of Revenue |
Research and Development | Research and DevelopmentResearch and development expenses consist primarily of salary and related expenses, including stock-based compensation, for personnel related to the development of improvements and expanded features for the Company’s solution, as well as quality assurance, testing, product management and allocated overhead. Research and development costs are expensed as incurred except for internal use software development costs that qualify for capitalization. The Company reviews development costs incurred for internal-use software in the application development stage and assesses costs for capitalization. |
Advertising Costs | Advertising CostsThe Company primarily advertises its services through the internet and in conjunction with partners. |
Commissions | CommissionsCommissions consist of variable compensation earned by sales personnel and referral fees the Company pays to third parties. The Company defers all incremental commission costs to obtain the contract, and amortizes these costs over a period of benefit determined to be five years. |
Stock-Based Compensation | Stock-Based Compensation All stock-based compensation granted to employees and non-employee directors is measured at the grant date fair value of the award. The Company estimates the fair value of stock options under the Company’s Equity Incentive Plans and purchase rights under the Company’s 2014 Employee Stock Purchase Plan (“2014 ESPP Plan” or “ESPP”) using the Black-Scholes option-pricing model. The fair value of restricted stock units (“RSUs”), including performance-based restricted stock units (“PRSUs”) subject to performance conditions, is equal to the fair value of the Company’s common stock on the date of grant. The fair value of PRSUs subject to market conditions are determined using a Monte Carlo Simulation model. Compensation expense is recognized net of actual forfeitures using the straight-line method over the service period, which is generally the vesting period. |
Income Taxes | Income Taxes The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in operations in the period that includes the enactment date. The Company records a valuation allowance to reduce its deferred tax assets to the amount of future tax benefit that is more likely than not to be realized. As of December 31, 2022, and 2021, the Company recorded a full valuation allowance against the U.S. net deferred tax assets because of its history of operating losses in the United States. As of December 31, 2022 and 2021, the Company recognized a net deferred tax asset balance of $3.8 million and $6.9 million, respectively, related to its |
Comprehensive loss | Comprehensive loss Comprehensive loss consists of net loss, and unrealized gains or losses on available-for-sale marketable investments. The Company presents comprehensive loss as part of the consolidated statements of operations. The changes in the accumulated balances of the components of other comprehensive loss were not material for the periods presented. |
Net Loss Per Share | Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted average number of shares of common stock outstanding during the period, and excludes any dilutive effects of employee stock-based awards and potential shares issuable upon conversion of the convertible senior notes. Diluted net loss per share is computed giving effect to all potentially dilutive shares of common stock, including common stock issuable upon exercise of stock options, vesting of RSUs and PRSUs, and shares of common stock issuable upon conversion of convertible senior notes. In periods of net loss, all potentially issuable shares of common stock are excluded from the diluted net loss per share computation because they are anti-dilutive. Therefore, basic and diluted net loss per share are the same for all years presented in the Company’s consolidated statements of operations and comprehensive loss. |
Indemnification | IndemnificationThe Company, in the ordinary course of business, enters into agreements of varying scope and terms pursuant to which it agrees to indemnify clients, vendors, lessors, business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, including breach of security, services to be provided by the Company or from intellectual property infringement claims made by third parties. |
Segment Information | Segment Information The Company has determined that its Chief Executive Officer is its chief operating decision maker. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of assessing performance and making decisions on how to allocate resources. Accordingly, the Company has determined that it operates in a single reportable segment. |
Recent Accounting Pronouncements Not Yet Effective | Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows. |
Description of Business and S_3
Description of Business and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Schedule of Allowance for Doubtful Accounts | The following table presents the changes in the allowance for doubtful accounts (in thousands): Year Ended December 31, 2022 2021 Balance, beginning of period $ 220 $ 127 Add: bad debt expense 1,105 808 Less: write-offs, net of recoveries (1,063) (715) Balance, end of period $ 262 $ 220 |
Schedule of Estimated Useful Lives | Property and equipment is stated at cost less accumulated depreciation and amortization, and is depreciated using the straight-line method over the estimated useful lives of the assets as follows: Asset Category Estimated Useful Lives Computer and network equipment 3 to 5 years Computer software 3 years Internal-use software and development costs 1 to 5 years Furniture and fixtures 7 years Leasehold improvements Shorter of useful life or lease term |
Revenue (Tables)
Revenue (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Contract Balances | The following table provides information about accounts receivable, net, deferred contract acquisition costs, net, contract assets and contract liabilities from contracts with customers (in thousands): December 31, 2022 December 31, 2021 Accounts receivable, net $ 87,494 $ 83,731 Deferred contract acquisition costs, net: Current $ 47,242 $ 33,295 Non-current 114,880 84,663 Total deferred contract acquisition costs, net $ 162,122 $ 117,958 Contract assets and contract liabilities: Contract assets (included in prepaid expenses and other current assets) $ 3,401 $ 2,593 Contract liabilities (deferred revenue) 57,816 43,720 Noncurrent contract liabilities (deferred revenue) (included in other long term liabilities) 1,178 2,097 Net contract liabilities $ (55,593) $ (43,224) |
Investments and Fair Value Me_2
Investments and Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Marketable Investments | The Company’s marketable investments have been classified and accounted for as available-for-sale. The Company’s marketable investments as of December 31, 2022 and 2021 were as follows (in thousands): December 31, 2022 Short-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 747 $ — $ (13) $ 734 U.S. treasury securities 186,776 8 (1,382) 185,402 U.S. agency and government-sponsored securities 197,597 29 (1,660) 195,966 Commercial paper 25,386 — — 25,386 Municipal bonds 22,764 — (145) 22,619 Corporate bonds 3,658 — (22) 3,636 Total $ 436,928 $ 37 $ (3,222) $ 433,743 December 31, 2022 Long-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. agency securities $ 885 $ — $ — $ 885 Total $ 885 $ — $ — $ 885 December 31, 2021 Short-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 1,615 $ — $ — $ 1,615 U.S. treasury securities 83,237 — (24) 83,213 U.S. agency securities 159,070 — (65) 159,005 Commercial paper 47,555 — — 47,555 Municipal bonds 75,337 — (96) 75,241 Corporate bonds 12,355 2 (6) 12,351 Total $ 379,169 $ 2 $ (191) $ 378,980 December 31, 2021 Long-Term Marketable Investments Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Certificates of deposit $ 746 $ — $ (2) $ 744 U.S. treasury securities 63,566 — (251) 63,315 U.S. agency securities 63,960 — (254) 63,706 Municipal bonds 18,655 — (64) 18,591 Corporate bonds 1,026 — (5) 1,021 Total $ 147,953 $ — $ (576) $ 147,377 |
Schedule of Gross Unrealized Losses and Fair Value of Marketable Investments | The following table presents the gross unrealized losses and the fair value for those marketable investments that were in an unrealized loss position for less than 12 months as of December 31, 2022 and 2021 (in thousands): December 31, 2022 December 31, 2021 Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Certificates of deposit $ (13) $ 734 $ (2) $ 2,010 U.S. treasury securities (1,382) 126,534 (275) 140,527 U.S. agency securities (1,660) 172,458 (320) 222,710 Municipal bonds (145) 12,623 (160) 87,184 Corporate bonds (22) 3,636 (10) 9,428 Total $ (3,222) $ 315,985 $ (767) $ 461,859 |
Schedule of Assets Carried at Fair Value | The following tables set forth the Company’s assets measured at fair value by level within the fair value hierarchy (in thousands): December 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents Money market funds $ 37,560 $ — $ — $ 37,560 U.S. treasury securities 19,700 — — 19,700 Total cash equivalents $ 57,260 $ — $ — $ 57,260 Marketable investments (short and long-term) Certificates of deposit $ — $ 734 $ — $ 734 U.S. treasury securities 185,402 — — 185,402 U.S. agency and government sponsored securities — 196,851 — 196,851 Commercial paper — 25,386 — 25,386 Municipal bonds — 22,619 — 22,619 Corporate bonds — 3,636 — 3,636 Total marketable investments $ 185,402 $ 249,226 $ — $ 434,628 December 31, 2021 Level 1 Level 2 Level 3 Total Assets Cash equivalents Money market funds $ 31,380 $ — $ — $ 31,380 Certificates of deposit — 747 — 747 Total cash equivalents $ 31,380 $ 747 $ — $ 32,127 Marketable investments (short and long-term) Certificates of deposit $ — $ 2,359 $ — $ 2,359 U.S. Treasury 146,528 — — 146,528 U.S. agency and government sponsored securities — 222,711 — 222,711 Commercial paper — 47,555 — 47,555 Municipal bonds — 93,832 — 93,832 Corporate bonds — 13,372 — 13,372 Total marketable investments $ 146,528 $ 379,829 $ — $ 526,357 Liabilities Contingent consideration $ — $ — $ 23,740 $ 23,740 |
Schedule of Changes for Contingent Consideration Liabilities | A reconciliation of the beginning and ending balance for contingent consideration consisted of the following (in thousands): Contingent Consideration Balance, December 31. 2020 $ 18,100 Change in fair value of contingent consideration 5,640 Balance, December 31, 2021 23,740 Change in fair value of contingent consideration 260 Less: Payment (24,000) Balance, December 31, 2022 $ — |
Financial Statement Components
Financial Statement Components (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Financial Statement Components [Abstract] | |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents consisted of the following (in thousands): December 31, 2022 2021 Cash $ 123,260 $ 58,751 Certificates of deposit — 747 Money market funds 37,560 31,380 U.S. Treasury 19,700 — Total cash and cash equivalents $ 180,520 $ 90,878 |
Schedule of Accounts Receivable | Accounts receivable, net consisted of the following (in thousands): December 31, 2022 2021 Trade accounts receivable $ 77,621 $ 75,970 Unbilled trade accounts receivable, net of advance client deposits 10,135 7,981 Allowance for doubtful accounts (262) (220) Accounts receivable, net $ 87,494 $ 83,731 |
Schedule of Prepaid Expenses and Other Current Assets | Prepaid expenses and other current assets consisted of the following (in thousands): December 31, 2022 2021 Prepaid expenses $ 17,151 $ 21,306 Other current assets 9,159 6,443 Contract assets 3,401 2,593 Prepaid expenses and other current assets $ 29,711 $ 30,342 |
Schedule of Property and Equipment | Property and equipment, net consisted of the following (in thousands): December 31, 2022 2021 Computer and network equipment $ 148,789 $ 116,701 Computer software 50,955 44,268 Internal-use software development costs 6,111 500 Furniture and fixtures 3,326 3,953 Leasehold improvements 6,574 5,914 Property and equipment 215,755 171,336 Accumulated depreciation and amortization (114,534) (93,551) Property and equipment, net $ 101,221 $ 77,785 Property and equipment capitalized under finance lease obligations consists primarily of computer and network equipment and was as follows (in thousands): December 31, 2022 2021 Gross $ 36,282 $ 42,541 Less: accumulated depreciation and amortization (36,203) (41,689) Total $ 79 $ 852 |
Schedule of Other Assets | Other assets consisted of the following (in thousands): December 31, 2022 2021 Other assets $ 5,081 $ 4,964 Equity investment in a privately-held company 2,000 — Deferred tax assets 3,976 6,907 Other assets $ 11,057 $ 11,871 |
Schedule of Accrued and Other Current Liabilities | Accrued and other current liabilities consisted of the following (in thousands): December 31, 2022 2021 Accrued expenses $ 19,343 $ 20,108 Accrued compensation and benefits 33,749 34,729 Contingent consideration — 23,740 Accrued and other current liabilities $ 53,092 $ 78,577 |
Schedule of Long-Term Liabilities | Other long-term liabilities consisted of the following (in thousands): December 31, 2022 2021 Deferred revenue $ 1,178 $ 2,097 Deferred tax liabilities 157 — Other long-term liabilities 1,745 5,574 Other long-term liabilities $ 3,080 $ 7,671 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible Assets Activity | The following table summarizes the activity in the Company's intangible asset balances during the years ended December 31, 2022 and 2021 (in thousands): Intangible Assets Beginning of the period, January 1, 2021 $ 51,684 Amortization (11,787) End of the period, December 31, 2021 39,897 Amortization (11,705) End of the period, December 31, 2022 $ 28,192 |
Schedule of Intangible Assets | The components of intangible assets were as follows (in thousands): December 31, 2022 December 31, 2021 Gross Carrying Amount Accumulated Net Weighted Average Remaining Amortization Period (Years) Gross Accumulated Net Weighted Average Remaining Amortization Period (Years) Developed technology $ 56,214 $ (28,881) $ 27,333 3.2 $ 56,214 $ (17,821) $ 38,393 4.0 Acquired workforce 470 (470) — 0.0 470 (334) 136 0.9 Customer relationships 1,600 (741) 859 2.7 1,600 (421) 1,179 3.7 Trademarks 500 (500) — 0.0 500 (311) 189 0.9 Total $ 58,784 $ (30,592) $ 28,192 3.2 $ 58,784 $ (18,887) $ 39,897 4.0 |
Schedule of Expected Future Amortization Expense of Intangible Assets | As of December 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 $ 10,870 2024 7,527 2025 5,595 2026 4,200 2027 — Thereafter — Total $ 28,192 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Convertible Senior Notes, Due 2025 | |
Debt Instrument [Line Items] | |
Schedule of Net Carrying Amount of Notes and Impact to Additional Paid-in Capital | The net carrying amount of the 2025 convertible senior notes as of December 31, 2022 and 2021 was as follows (in thousands): December 31, 2022 December 31, 2021 Principal $ 747,500 $ 747,500 Unamortized issuance costs (9,124) (12,835) Net carrying amount $ 738,376 $ 734,665 |
Schedule of Interest Expense Related to the Notes | Interest expense related to the 2025 convertible senior notes was as follows (in thousands): Year Ended December 31, 2022 December 31, 2021 December 31, 2020 Contractual interest expense $ 3,737 $ 4,007 $ 2,230 Amortization of debt discount — — 16,528 Amortization of issuance costs 3,711 3,674 1,538 Total interest expense $ 7,448 $ 7,681 $ 20,296 |
Convertible Senior Notes, Due 2023 | |
Debt Instrument [Line Items] | |
Schedule of Net Carrying Amount of Notes and Impact to Additional Paid-in Capital | The net carrying amount of the 2023 convertible senior notes as of December 31, 2022 and 2021 was as follows (in thousands): December 31, 2022 December 31, 2021 Principal $ 169 $ 34,225 Unamortized issuance costs — (291) Net carrying amount $ 169 $ 33,934 |
Schedule of Interest Expense Related to the Notes | Interest expense related to the 2023 convertible senior notes was as follows (in thousands): Year Ended December 31, 2022 December 31, 2021 December 31, 2020 Contractual interest expense $ 6 $ 42 $ 184 Amortization of debt discount — — 7,006 Amortization of issuance costs 32 283 666 Total interest expense $ 38 $ 325 $ 7,856 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Schedule of Common Stock Reserved for Future Issuance | Shares of common stock reserved for future issuance related to outstanding equity awards and employee equity incentive plans as of December 31, 2022, were as follows (in thousands): Common Stock Reserved Stock options outstanding 1,481 RSUs (including PRSUs) outstanding 3,718 Shares available for future grant under 2014 Plan 14,230 Shares available for future issuance under ESPP 3,570 Total shares of common stock reserved 22,999 |
Schedule of Stock Option Activities | A summary of the Company’s stock option activity during the year ended December 31, 2022 is as follows (in thousands, except years and per share data): Number of Shares Weighted Weighted Aggregate Intrinsic Value (1) Outstanding as of December 31, 2021 1,982 $ 38.65 Options granted 81 110.05 Options exercised (531) 16.06 Options forfeited or expired (51) 122.88 Outstanding as of December 31, 2022 1,481 47.75 4.6 $ 51,226 Vested and expected to vest as of December 31, 2022 1,481 47.75 4.6 51,226 Exercisable as of December 31, 2022 1,263 35.60 4.0 50,583 (1) The aggregate intrinsic value amounts are computed based on the difference between the exercise price of the stock options and the fair market value of the Company’s common stock of $67.86 per share as of December 30, 2022 for all in-the-money stock options outstanding. Following is additional information pertaining to the Company’s stock option activity (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Weighted average grant date fair value per share of options granted, excluding assumed stock options $ 50.44 $ 78.72 $ 38.80 Weighted average grant date fair value per share of assumed stock options — — 125.96 Intrinsic value of options exercised (1) 45,698 59,762 47,529 Total fair value of options vested during the period 11,421 12,760 7,846 Cash received from options exercised 8,522 7,402 11,656 (1) Intrinsic value of options exercised is the difference between the fair market value of the Company’s common stock at the time of exercise and the exercise price paid. |
Schedule of RSU Activities | A summary of RSU activity (including PRSUs) during the year ended December 31, 2022 is as follows (in thousands, except years and per share data): Number of Shares Weighted Average Grant Date Fair Value Per Share Outstanding as of December 31, 2021 2,560 $ 125.65 RSUs granted (1) 2,912 90.51 RSUs vested and released (1,383) 112.18 RSUs forfeited or cancelled (371) 121.48 Outstanding as of December 31, 2022 3,718 103.55 Following is additional information pertaining to the Company’s RSU activity (including PRSUs) (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Weighted average grant date fair value per share of RSUs granted $ 90.51 $ 177.00 $ 86.15 Total fair value of RSUs vested during the period 125,798 174,500 136,805 |
Schedule of Stock-Based Compensation Expense | Stock-based compensation expenses for the years ended December 31, 2022, 2021 and 2020 were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Cost of revenue $ 33,297 $ 17,734 $ 9,422 Research and development 44,367 29,179 14,043 Sales and marketing 59,300 35,269 20,164 General and administrative 35,543 26,623 21,118 Total stock-based compensation $ 172,507 $ 108,805 $ 64,747 |
Schedule of Unrecognized Compensation Expense | As of December 31, 2022, unrecognized stock-based compensation expense by award type and their expected weighted-average recognition periods are summarized in the following table (in thousands, except years). Stock Option RSU (excluding PRSUs) PRSU ESPP Unrecognized stock-based compensation expense $ 12,085 $ 324,834 $ 24,841 $ 3,265 Weighted-average amortization period 2.2 years 2.4 years 2.5 years 0.4 years |
Schedule of Valuation Assumptions, Stock Option | The weighted average assumptions used to value stock options granted during the periods presented were as follows: Stock Options Year Ended December 31, 2022 2021 2020 (1) Expected term (years) 6.0 6.0 5.7 Volatility 46% 47% 47% Risk-free interest rate 1.8% 1.0% 0.9% Dividend yield — — — (1) The weighted average assumptions for the year ended December 31, 2020 includes assumed stock options. The weighted average assumptions, excluding the assumed stock options, were an expected term of 6.0 years, volatility of 47%, risk-free interest rate of 1.0% and dividend yield of 0%. The weighted average assumptions of the assumed stock options were an expected term of 4.3 years, volatility of 47%, risk-free interest rate of 0.3% and dividend yield of 0%. The weighted average assumptions used to value PRSUs with market conditions granted during the periods presented were as follows: PRSUs (Market Conditions) Year Ended December 31, 2022 2021 2020 Expected term (years) 3.0 — — Volatility 53% — — Risk-free interest rate 3.5% — — Dividend yield — — — |
Schedule of Valuation Assumptions for Stock Option Purchase Plan | The weighted average assumptions used to value purchase rights under the 2014 ESPP granted during the periods presented were as follows: ESPP Granted In November 2022 May 2022 November 2021 May 2021 November 2020 May 2020 Expected term (years) 0.5 0.5 0.5 0.5 0.5 0.5 Volatility 59% 46% 46% 49% 50% 50% Risk-free interest rate 2.1% 0.2% 0.2% 0.1% 0.1% 0.2% Dividend yield — — — — — — |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of Basic and Diluted Net Loss Per Share | The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Year Ended December 31, 2022 2021 2020 Net loss $ (94,650) $ (53,000) $ (42,130) Weighted-average shares used in computing basic and diluted net loss per share 69,920 67,512 64,154 Basic and diluted net loss per share $ (1.35) $ (0.79) $ (0.66) |
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share | The following securities were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive (in thousands): December 31, 2022 2021 2020 Stock options 1,481 1,982 2,255 RSUs (including PRSUs) 3,718 2,560 2,267 Convertible senior notes (1) 5,685 6,663 910 Total 10,884 11,205 5,432 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Loss Before Income Taxes | The following table presents components of loss before income taxes for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 United States $ (76,280) $ (59,856) $ (44,303) International (13,982) (4,429) (280) Loss before income taxes $ (90,262) $ (64,285) $ (44,583) |
Schedule of Components of Provision for Income Taxes | Provision for (benefit from) income taxes for the periods presented consisted of (in thousands): Year Ended December 31, 2022 2021 2020 Current: U.S. federal $ — $ — $ — U.S. state 576 262 401 Foreign 724 (202) 233 Total provision for income taxes - Current 1,300 60 634 Deferred: U.S. federal — — (2,495) U.S. state — — (414) Foreign 3,088 (11,345) (178) Total provision for (benefit from) income taxes - Deferred 3,088 (11,345) (3,087) Total provision for (benefit from) income taxes $ 4,388 $ (11,285) $ (2,453) |
Schedule of Effective Income Tax Reconciliation | Income tax (benefit) expense differed from the amount computed by applying the U.S. federal statutory income tax rate of 21% to pre-tax (loss) income for the periods presented as a result of the following (in thousands): Year Ended December 31, 2022 2021 2020 U.S. federal tax at statutory rate $ (18,957) $ (13,500) $ (9,362) U.S. state income taxes 576 262 (345) Section 162(m) 3,851 7,543 6,472 Global intangible low-taxed income 4,127 — — Non-deductible expenses 78 1,361 1,944 Research and development credit (1,194) (1,181) (837) Stock-based compensation 1,722 (25,241) (23,800) Tax benefit from acquisition/reorganizations (3,852) (5,877) (2,495) Foreign taxes 6,749 (4,760) 118 Other — 20 533 Change in valuation allowance 11,288 30,088 25,319 Total provision for (benefit from) income taxes $ 4,388 $ (11,285) $ (2,453) |
Schedule of Deferred Tax Assets and Liabilities | The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities as of December 31, 2022 and 2021 related to the following (in thousands): December 31, 2022 2021 Deferred tax assets: Net operating loss and credit carryforwards $ 125,698 $ 133,433 Capitalized R&D costs 30,552 — Accrued liabilities 10,295 12,719 Allowance for doubtful accounts 1,143 712 Amortized intangibles 3,041 872 Deferred revenue 1,992 1,351 Accrued compensation 3,238 3,963 Long-term lease liabilities 12,421 13,618 Gross deferred tax assets 188,380 166,668 Valuation allowance (135,406) (121,835) Net deferred tax assets 52,974 44,833 Deferred tax liabilities: Property and equipment (2,737) (2,633) Other (556) (509) Right of use assets (10,419) (11,573) Deferred compensation - Current (35,443) (23,211) Gross deferred tax liabilities (49,155) (37,926) Net deferred taxes $ 3,819 $ 6,907 |
Schedule of Unrecognized Tax Benefits Rollforward | The table below shows the changes in the gross amount of unrecognized tax benefits for the periods presented (in thousands): Year Ended December 31, 2022 2021 2020 Unrecognized benefit — beginning of period $ 7,643 $ 6,076 $ 4,471 Gross increases — current year tax positions 1,773 1,851 1,605 Gross decreases — prior year tax positions (1) — — Settlements with tax authorities — (284) — Unrecognized benefit — end of period $ 9,415 $ 7,643 $ 6,076 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Future Minimum Lease Payments for Hosting, Telecommunication Usage Services | As of December 31, 2022, future minimum payments under these arrangements were as follows in thousands): Year Ending December 31, Hosting Services Telecommunication Usage Services 2023 $ 588 $ 7,467 2024 238 5,940 2025 4 1,304 2026 — 459 Thereafter $ — $ — Total future minimum payment $ 830 $ 15,170 |
Geographical Information (Table
Geographical Information (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Segment Reporting [Abstract] | |
Schedule of Revenues and Property and Equipment by Geographic Region | The following table summarizes revenues by geographic region based on client billing address (in thousands): Year Ended December 31, 2022 2021 2020 United States $ 702,206 $ 556,385 $ 400,509 International 76,640 53,206 34,399 Total revenue $ 778,846 $ 609,591 $ 434,908 The following table summarizes total property and equipment, net in the respective locations (in thousands): December 31, 2022 2021 United States $ 92,659 $ 68,674 International 8,562 9,111 Property and equipment, net $ 101,221 $ 77,785 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Schedule of Lease Obligations | The components of lease expenses were as follows (in thousands): Year Ended December 31, 2022 2021 2020 Operating lease cost $ 12,072 $ 10,238 $ 6,142 Finance lease cost: Amortization of right-of-use assets $ 56 $ 438 $ 748 Interest on finance lease liabilities — — 212 Total finance lease cost $ 56 $ 438 $ 960 Supplemental cash flow information related to leases was as follows (in thousands): Year Ended December 31, 2022 2021 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash used in operating leases $ (11,684) $ (7,178) $ (6,531) Financing cash used in finance leases — (612) (3,715) Right of use assets obtained in exchange for lease obligations: Operating leases 5,984 50,101 5,980 Finance leases — — — Weighted average remaining terms were as follows (in years): December 31, 2022 2021 Weighted average remaining lease term Operating leases 6.4 years 7.3 years Finance leases 0.0 years 0.0 years Weighted average discount rates were as follows: December 31, 2022 2021 Weighted average discount rate Operating leases 3.4 % 3.2 % Finance leases — % — % |
Schedule of Balance Sheet Information Related to Leases | Supplemental balance sheet information related to leases was as follows (in thousands): December 31, 2022 2021 Operating leases Operating lease right-of-use assets $ 44,120 $ 48,703 Operating lease liabilities: $ 10,626 $ 9,826 Operating lease liabilities — less current portion 41,389 47,088 Total operating lease liabilities $ 52,015 $ 56,914 Finance leases Property and equipment, gross $ 36,282 $ 42,541 Less: accumulated depreciation and amortization (36,203) (41,689) Property and equipment, net $ 79 $ 852 |
Schedule of Operating Lease Maturities | Maturities of lease liabilities were as follows (in thousands): Year Ending December 31, Operating Leases 2023 $ 12,246 2024 9,986 2025 7,144 2026 5,679 2027 5,718 Thereafter 17,081 Total future minimum lease payments 57,854 Less: imputed interest (5,839) Total $ 52,015 |
Schedule of Finance Lease Maturities | Maturities of lease liabilities were as follows (in thousands): Year Ending December 31, Operating Leases 2023 $ 12,246 2024 9,986 2025 7,144 2026 5,679 2027 5,718 Thereafter 17,081 Total future minimum lease payments 57,854 Less: imputed interest (5,839) Total $ 52,015 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The following table presents the final allocation of the purchase price at the acquisition date (in thousands): Cash $ 1,394 Property and equipment acquired 124 Other assets acquired 2,238 Acquired technology 28,600 Customer relationships 1,100 Trade name and trademarks 400 Goodwill 130,976 Total assets acquired 164,832 Liabilities assumed (3,525) Deferred tax liability (4,616) Total consideration $ 156,691 Total consideration (net of cash acquired) $ 155,297 (in thousands): Cash $ 168 Tangible assets acquired 200 Acquired technology 12,200 Customer relationships 500 Trade name and trademarks 100 Goodwill 22,646 Total assets acquired 35,814 Deferred tax liability (2,910) Liabilities assumed (682) Total $ 32,222 |
Selected Quarterly Financial _2
Selected Quarterly Financial Data (Unaudited) (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Quarterly Financial Information Disclosure [Abstract] | |
Schedule of Quarterly Financial Information | Selected quarterly financial information for 2022 and 2021 is as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands, except per share data) Revenue $ 208,345 $ 198,342 $ 189,382 $ 182,777 $ 173,599 $ 154,328 $ 143,782 $ 137,882 Cost of revenue (1)(2) 96,294 94,111 88,229 88,867 79,764 67,137 64,395 59,803 Gross profit 112,051 104,231 101,153 93,910 93,835 87,191 79,387 78,079 Operating expenses: Research and development (1)(2) 36,865 34,113 34,992 35,824 30,448 29,680 24,648 22,121 Sales and marketing (1)(2) 65,928 67,353 64,098 64,611 53,394 49,712 46,024 44,799 General and administrative (1)(2) 22,509 24,496 23,824 24,314 21,972 26,790 22,909 22,245 Total operating expenses 125,302 125,962 122,914 124,749 105,814 106,182 93,581 89,165 Loss from operations (13,251) (21,731) (21,761) (30,839) (11,979) (18,991) (14,194) (11,086) Other (expense) income, net: Interest expense (1,887) (1,879) (1,857) (1,870) (2,024) (1,947) (2,118) (1,938) Other (expense) and interest income 2,706 982 280 845 (43) 213 (353) 175 Total other (expense) income, net 819 (897) (1,577) (1,025) (2,067) (1,734) (2,471) (1,763) Loss before income taxes (12,432) (22,628) (23,338) (31,864) (14,046) (20,725) (16,665) (12,849) Provision for (benefit from) income taxes 1,221 579 332 2,256 (10,445) (188) (135) (517) Net loss $ (13,653) $ (23,207) $ (23,670) $ (34,120) $ (3,601) $ (20,537) $ (16,530) $ (12,332) Net loss per share: Basic $ (0.19) $ (0.33) $ (0.34) $ (0.49) $ (0.05) $ (0.30) $ (0.25) $ (0.18) Diluted $ (0.19) $ (0.33) $ (0.34) $ (0.49) $ (0.05) $ (0.30) $ (0.25) $ (0.18) Shares used in computing net loss per share: Basic 70,704 70,232 69,748 68,974 68,207 67,800 67,292 66,721 Diluted 70,704 70,232 69,748 68,974 68,207 67,800 67,292 66,721 (1) Included stock-based compensation as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands) Cost of revenue $ 8,638 $ 8,329 $ 8,538 $ 7,793 $ 6,854 $ 3,994 $ 3,781 $ 3,105 Research and development 11,799 10,603 11,818 10,145 9,163 9,101 6,152 4,763 Sales and marketing 15,152 15,761 14,963 13,424 11,987 8,304 8,208 6,771 General and administrative 8,235 9,810 9,467 8,032 7,597 5,996 6,760 6,269 Total stock-based compensation $ 43,824 $ 44,503 $ 44,786 $ 39,394 $ 35,601 $ 27,395 $ 24,901 $ 20,908 (2) Included depreciation and amortization expenses as follows: Quarter Ended Dec. 31, 2022 Sept. 30, 2022 Jun. 30, 2022 Mar. 31, 2022 Dec. 31, 2021 Sept. 30, 2021 Jun. 30, 2021 Mar. 31, 2021 (unaudited, in thousands) Cost of revenue $ 8,803 $ 8,904 $ 8,747 $ 8,500 $ 8,301 $ 7,658 $ 7,825 $ 7,087 Research and development 768 768 804 825 948 1,004 729 596 Sales and marketing 1 1 1 1 1 1 1 1 General and administrative 1,449 1,542 2,088 1,469 1,288 1,117 1,096 1,079 Total depreciation and amortization $ 11,021 $ 11,215 $ 11,640 $ 10,795 $ 10,538 $ 9,780 $ 9,651 $ 8,763 |
Description of Business and S_4
Description of Business and Summary of Significant Accounting Policies - Termination of Zoom Proposed Merger and Basis of Presentation (Details) $ in Millions | 3 Months Ended |
Sep. 30, 2021 USD ($) | |
Five9, Inc. | Five9, Inc. | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Business combination, acquisition related costs | $ 7.6 |
Description of Business and S_5
Description of Business and Summary of Significant Accounting Policies - Concentration Risks (Details) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
Accounting Policies [Abstract] | ||
Cash, uninsured amount | $ 178.6 | $ 89.2 |
Description of Business and S_6
Description of Business and Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Allowance for Doubtful Accounts Receivable [Roll Forward] | |||
Balance, beginning of period | $ 220 | $ 127 | |
Add: bad debt expense | 1,105 | 808 | $ 754 |
Less: write-offs, net of recoveries | (1,063) | (715) | |
Balance, end of period | $ 262 | $ 220 | $ 127 |
Description of Business and S_7
Description of Business and Summary of Significant Accounting Policies - Schedule of Property and Equipment, Net (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Computer and network equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 3 years |
Computer and network equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 5 years |
Computer software | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 3 years |
Internal-use software and development costs | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 3 years |
Internal-use software and development costs | Minimum | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 1 year |
Internal-use software and development costs | Maximum | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 5 years |
Furniture and fixtures | |
Property, Plant and Equipment [Line Items] | |
Useful life, in years | 7 years |
Description of Business and S_8
Description of Business and Summary of Significant Accounting Policies - Goodwill and Intangible Assets (Details) | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average remaining amortization period | 3 years 2 months 12 days | 4 years |
Minimum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average remaining amortization period | 3 years | |
Maximum | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average remaining amortization period | 6 years |
Description of Business and S_9
Description of Business and Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | |||
Advertising expense | $ 28.1 | $ 20.8 | $ 15.6 |
Description of Business and _10
Description of Business and Summary of Significant Accounting Policies - Commissions (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | |||
Amortization period of capitalized contract cost (in years) | 5 years | ||
Commission expense | $ 47.3 | $ 31.1 | $ 21.9 |
Description of Business and _11
Description of Business and Summary of Significant Accounting Policies - Income Taxes (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Tax Credit Carryforward [Line Items] | ||
Deferred tax assets | $ 3,819 | $ 6,907 |
U.K. and Australia | ||
Tax Credit Carryforward [Line Items] | ||
Deferred tax assets | $ 3,800 | $ 6,900 |
Revenue - Contract Balances (De
Revenue - Contract Balances (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Revenue from Contract with Customer [Abstract] | ||
Accounts receivable, net | $ 87,494 | $ 83,731 |
Deferred contract acquisition costs, net: | ||
Current | 47,242 | 33,295 |
Non-current | 114,880 | 84,663 |
Total deferred contract acquisition costs, net | 162,122 | 117,958 |
Contract assets and contract liabilities: | ||
Contract assets (included in prepaid expenses and other current assets) | 3,401 | 2,593 |
Contract liabilities (deferred revenue) | 57,816 | 43,720 |
Noncurrent contract liabilities (deferred revenue) (included in other long term liabilities) | 1,178 | 2,097 |
Net contract liabilities | $ (55,593) | $ (43,224) |
Revenue - Narrative (Details)
Revenue - Narrative (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Amortization period of capitalized contract cost (in years) | 5 years |
Contract revenue recognized | $ 37.7 |
Remaining performance obligation | $ 758.9 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01 | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Performance obligation satisfaction period (in months) | 24 months |
Remaining performance obligation, percentage | 75% |
Contract Acquisition Costs | |
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |
Amortization period of capitalized contract cost (in years) | 5 years |
Investments and Fair Value Me_3
Investments and Fair Value Measurements - Schedule of Marketable Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | $ 434,628 | $ 526,357 |
Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 436,928 | 379,169 |
Gross Unrealized Gains | 37 | 2 |
Gross Unrealized Losses | (3,222) | (191) |
Fair Value | 433,743 | 378,980 |
Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 885 | 147,953 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | (576) |
Fair Value | 885 | 147,377 |
Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 734 | 2,359 |
Certificates of deposit | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 747 | 1,615 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (13) | 0 |
Fair Value | 734 | 1,615 |
Certificates of deposit | Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 746 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (2) | |
Fair Value | 744 | |
U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 185,402 | 146,528 |
U.S. treasury securities | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 186,776 | 83,237 |
Gross Unrealized Gains | 8 | 0 |
Gross Unrealized Losses | (1,382) | (24) |
Fair Value | 185,402 | 83,213 |
U.S. treasury securities | Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 63,566 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (251) | |
Fair Value | 63,315 | |
U.S. agency and government-sponsored securities | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 197,597 | 159,070 |
Gross Unrealized Gains | 29 | 0 |
Gross Unrealized Losses | (1,660) | (65) |
Fair Value | 195,966 | 159,005 |
U.S. agency and government-sponsored securities | Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 885 | 63,960 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | (254) |
Fair Value | 885 | 63,706 |
Commercial paper | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 25,386 | 47,555 |
Commercial paper | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 25,386 | 47,555 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 25,386 | 47,555 |
Municipal bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 22,619 | 93,832 |
Municipal bonds | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 22,764 | 75,337 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (145) | (96) |
Fair Value | 22,619 | 75,241 |
Municipal bonds | Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 18,655 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (64) | |
Fair Value | 18,591 | |
Corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 3,636 | 13,372 |
Corporate bonds | Short-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 3,658 | 12,355 |
Gross Unrealized Gains | 0 | 2 |
Gross Unrealized Losses | (22) | (6) |
Fair Value | $ 3,636 | 12,351 |
Corporate bonds | Long-Term Marketable Investments | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost | 1,026 | |
Gross Unrealized Gains | 0 | |
Gross Unrealized Losses | (5) | |
Fair Value | $ 1,021 |
Investments and Fair Value Me_4
Investments and Fair Value Measurements - Schedule of Gross Unrealized Losses and Fair Value of Marketable Investments (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | $ (3,222) | $ (767) |
Fair Value | 315,985 | 461,859 |
Certificates of deposit | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | (13) | (2) |
Fair Value | 734 | 2,010 |
U.S. treasury securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | (1,382) | (275) |
Fair Value | 126,534 | 140,527 |
U.S. agency and government-sponsored securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | (1,660) | (320) |
Fair Value | 172,458 | 222,710 |
Municipal bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | (145) | (160) |
Fair Value | 12,623 | 87,184 |
Corporate bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Gross Unrealized Losses | (22) | (10) |
Fair Value | $ 3,636 | $ 9,428 |
Investments and Fair Value Me_5
Investments and Fair Value Measurements - Schedule of Assets Carried at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Assets | ||
Cash equivalents | $ 57,260 | $ 32,127 |
Marketable investments | 434,628 | 526,357 |
Liabilities | ||
Contingent consideration | 23,740 | |
Level 1 | ||
Assets | ||
Cash equivalents | 57,260 | 31,380 |
Marketable investments | 185,402 | 146,528 |
Liabilities | ||
Contingent consideration | 0 | |
Level 2 | ||
Assets | ||
Cash equivalents | 0 | 747 |
Marketable investments | 249,226 | 379,829 |
Liabilities | ||
Contingent consideration | 0 | |
Level 3 | ||
Assets | ||
Cash equivalents | 0 | 0 |
Marketable investments | 0 | 0 |
Liabilities | ||
Contingent consideration | 23,740 | |
Certificates of deposit | ||
Assets | ||
Marketable investments | 734 | 2,359 |
Certificates of deposit | Level 1 | ||
Assets | ||
Marketable investments | 0 | 0 |
Certificates of deposit | Level 2 | ||
Assets | ||
Marketable investments | 734 | 2,359 |
Certificates of deposit | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
U.S. treasury securities | ||
Assets | ||
Marketable investments | 185,402 | 146,528 |
U.S. treasury securities | Level 1 | ||
Assets | ||
Marketable investments | 185,402 | 146,528 |
U.S. treasury securities | Level 2 | ||
Assets | ||
Marketable investments | 0 | 0 |
U.S. treasury securities | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
U.S. agency and government sponsored securities | ||
Assets | ||
Marketable investments | 196,851 | 222,711 |
U.S. agency and government sponsored securities | Level 1 | ||
Assets | ||
Marketable investments | 0 | 0 |
U.S. agency and government sponsored securities | Level 2 | ||
Assets | ||
Marketable investments | 196,851 | 222,711 |
U.S. agency and government sponsored securities | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
Commercial paper | ||
Assets | ||
Marketable investments | 25,386 | 47,555 |
Commercial paper | Level 1 | ||
Assets | ||
Marketable investments | 0 | 0 |
Commercial paper | Level 2 | ||
Assets | ||
Marketable investments | 25,386 | 47,555 |
Commercial paper | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
Municipal bonds | ||
Assets | ||
Marketable investments | 22,619 | 93,832 |
Municipal bonds | Level 1 | ||
Assets | ||
Marketable investments | 0 | 0 |
Municipal bonds | Level 2 | ||
Assets | ||
Marketable investments | 22,619 | 93,832 |
Municipal bonds | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
Corporate bonds | ||
Assets | ||
Marketable investments | 3,636 | 13,372 |
Corporate bonds | Level 1 | ||
Assets | ||
Marketable investments | 0 | 0 |
Corporate bonds | Level 2 | ||
Assets | ||
Marketable investments | 3,636 | 13,372 |
Corporate bonds | Level 3 | ||
Assets | ||
Marketable investments | 0 | 0 |
Money market funds | ||
Assets | ||
Cash equivalents | 37,560 | 31,380 |
Money market funds | Level 1 | ||
Assets | ||
Cash equivalents | 37,560 | 31,380 |
Money market funds | Level 2 | ||
Assets | ||
Cash equivalents | 0 | 0 |
Money market funds | Level 3 | ||
Assets | ||
Cash equivalents | 0 | 0 |
Certificates of deposit | ||
Assets | ||
Cash equivalents | 747 | |
Certificates of deposit | Level 1 | ||
Assets | ||
Cash equivalents | 0 | |
Certificates of deposit | Level 2 | ||
Assets | ||
Cash equivalents | 747 | |
Certificates of deposit | Level 3 | ||
Assets | ||
Cash equivalents | $ 0 | |
U.S. treasury securities | ||
Assets | ||
Cash equivalents | 19,700 | |
U.S. treasury securities | Level 1 | ||
Assets | ||
Cash equivalents | 19,700 | |
U.S. treasury securities | Level 2 | ||
Assets | ||
Cash equivalents | 0 | |
U.S. treasury securities | Level 3 | ||
Assets | ||
Cash equivalents | $ 0 |
Investments and Fair Value Me_6
Investments and Fair Value Measurements - Narrative (Details) - USD ($) | 12 Months Ended | |||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Feb. 28, 2022 | Nov. 30, 2020 | Nov. 18, 2020 | |
Debt Instrument [Line Items] | ||||||
Contingent consideration | $ 23,740,000 | |||||
Payment for contingent consideration liability | $ 18,100,000 | 0 | $ 0 | |||
Equity investment in a privately-held company | 2,000,000 | 0 | $ 2,000,000 | |||
Inference Solutions | ||||||
Debt Instrument [Line Items] | ||||||
Contingent consideration | $ 24,000,000 | $ 18,100,000 | ||||
Payment for contingent consideration liability | 24,000,000 | |||||
Level 2 | ||||||
Debt Instrument [Line Items] | ||||||
Contingent consideration | 0 | |||||
Level 3 | ||||||
Debt Instrument [Line Items] | ||||||
Contingent consideration | 23,740,000 | |||||
Nonrecurring | ||||||
Debt Instrument [Line Items] | ||||||
Assets and liabilities measured at fair value on nonrecurring basis | 0 | 0 | ||||
Convertible Senior Notes, Due 2023 | Level 2 | Convertible Debt | ||||||
Debt Instrument [Line Items] | ||||||
Fair value of long-term debt | 300,000 | 114,900,000 | ||||
Convertible Senior Notes, Due 2025 | Level 2 | Convertible Debt | ||||||
Debt Instrument [Line Items] | ||||||
Fair value of long-term debt | $ 687,100,000 | $ 917,300,000 |
Investments and Fair Value Me_7
Investments and Fair Value Measurements - Schedule of Changes for Contingent Consideration Liabilities (Details) - Liability - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Summary of changes in contingent consideration liabilities | ||
Change in fair value of contingent consideration | $ 260 | |
Less: Payment | (24,000) | |
Ending balance | 0 | |
Fair Value, Recurring | ||
Summary of changes in contingent consideration liabilities | ||
Beginning balance | $ 23,740 | $ 18,100 |
Change in fair value of contingent consideration | 5,640 | |
Ending balance | $ 23,740 |
Financial Statement Component_2
Financial Statement Components - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Cash and Cash Equivalents | ||||
Cash and cash equivalents | $ 180,520 | $ 90,878 | $ 220,372 | $ 77,976 |
Cash | ||||
Cash and Cash Equivalents | ||||
Cash and cash equivalents | 123,260 | 58,751 | ||
Certificates of deposit | ||||
Cash and Cash Equivalents | ||||
Cash and cash equivalents | 0 | 747 | ||
Money market funds | ||||
Cash and Cash Equivalents | ||||
Cash and cash equivalents | 37,560 | 31,380 | ||
U.S. Treasury | ||||
Cash and Cash Equivalents | ||||
Cash and cash equivalents | $ 19,700 | $ 0 |
Financial Statement Component_3
Financial Statement Components - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Accounts Receivable | |||
Allowance for doubtful accounts | $ (262) | $ (220) | $ (127) |
Accounts receivable, net | 87,494 | 83,731 | |
Trade accounts receivable | |||
Accounts Receivable | |||
Trade accounts receivable | 77,621 | 75,970 | |
Unbilled trade accounts receivable, net of advance client deposits | |||
Accounts Receivable | |||
Trade accounts receivable | $ 10,135 | $ 7,981 |
Financial Statement Component_4
Financial Statement Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Financial Statement Components [Abstract] | ||
Prepaid expenses | $ 17,151 | $ 21,306 |
Other current assets | 9,159 | 6,443 |
Contract assets | 3,401 | 2,593 |
Prepaid expenses and other current assets | $ 29,711 | $ 30,342 |
Financial Statement Component_5
Financial Statement Components - Schedule of Useful Lives of Property and Equipment (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Property, Plant and Equipment [Line Items] | |||
Property and equipment | $ 215,755 | $ 171,336 | |
Accumulated depreciation and amortization | (114,534) | (93,551) | |
Property and equipment, net | 101,221 | 77,785 | |
Depreciation and amortization of property and equipment | 33,000 | 26,900 | $ 18,200 |
Computer and network equipment | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment | 148,789 | 116,701 | |
Computer software | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment | 50,955 | 44,268 | |
Internal-use software development costs | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment | 6,111 | 500 | |
Furniture and fixtures | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment | 3,326 | 3,953 | |
Leasehold improvements | |||
Property, Plant and Equipment [Line Items] | |||
Property and equipment | $ 6,574 | $ 5,914 |
Financial Statement Component_6
Financial Statement Components - Schedule of Property and Equipment Capitalized Under Finance Lease Obligations (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Financial Statement Components [Abstract] | ||
Gross | $ 36,282 | $ 42,541 |
Less: accumulated depreciation and amortization | (36,203) | (41,689) |
Property and equipment, net | $ 79 | $ 852 |
Financial Statement Component_7
Financial Statement Components - Schedule of Other Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Feb. 28, 2022 | Dec. 31, 2021 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||
Other assets | $ 5,081 | $ 4,964 | |
Equity investment in a privately-held company | 2,000 | $ 2,000 | 0 |
Deferred tax assets | 3,976 | 6,907 | |
Other assets | $ 11,057 | $ 11,871 |
Financial Statement Component_8
Financial Statement Components - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Financial Statement Components [Abstract] | ||
Accrued expenses | $ 19,343 | $ 20,108 |
Accrued compensation and benefits | 33,749 | 34,729 |
Contingent consideration | 0 | 23,740 |
Accrued and other current liabilities | $ 53,092 | $ 78,577 |
Financial Statement Component_9
Financial Statement Components - Schedule of Other Long-term Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Financial Statement Components [Abstract] | ||
Deferred revenue | $ 1,178 | $ 2,097 |
Deferred tax liabilities | 157 | 0 |
Other long-term liabilities | 1,745 | 5,574 |
Other long-term liabilities | $ 3,080 | $ 7,671 |
Goodwill and Intangible Asset_2
Goodwill and Intangible Assets - Schedule of Intangible Asset Activity (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Goodwill impairment, accumulated | $ 0 | $ 0 | |
Intangible Assets [Roll Forward] | |||
Intangible assets, beginning balance | 39,897,000 | 51,684,000 | |
Amortization | (11,705,000) | (11,787,000) | $ (6,800,000) |
Intangible assets, ending balance | $ 28,192,000 | $ 39,897,000 | $ 51,684,000 |
Goodwill and Intangible Asset_3
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Acquired Finite-Lived Intangible Assets | |||
Gross Carrying Amount | $ 58,784 | $ 58,784 | |
Accumulated Amortization | (30,592) | (18,887) | |
Net Carrying Amount | $ 28,192 | $ 39,897 | $ 51,684 |
Weighted Average Remaining Amortization Period (Years) | 3 years 2 months 12 days | 4 years | |
Amortization of intangible assets | $ 11,705 | $ 11,787 | $ 6,800 |
Developed technology | |||
Acquired Finite-Lived Intangible Assets | |||
Gross Carrying Amount | 56,214 | 56,214 | |
Accumulated Amortization | (28,881) | (17,821) | |
Net Carrying Amount | $ 27,333 | $ 38,393 | |
Weighted Average Remaining Amortization Period (Years) | 3 years 2 months 12 days | 4 years | |
Acquired workforce | |||
Acquired Finite-Lived Intangible Assets | |||
Gross Carrying Amount | $ 470 | $ 470 | |
Accumulated Amortization | (470) | (334) | |
Net Carrying Amount | $ 0 | $ 136 | |
Weighted Average Remaining Amortization Period (Years) | 0 years | 10 months 24 days | |
Customer relationships | |||
Acquired Finite-Lived Intangible Assets | |||
Gross Carrying Amount | $ 1,600 | $ 1,600 | |
Accumulated Amortization | (741) | (421) | |
Net Carrying Amount | $ 859 | $ 1,179 | |
Weighted Average Remaining Amortization Period (Years) | 2 years 8 months 12 days | 3 years 8 months 12 days | |
Trademarks | |||
Acquired Finite-Lived Intangible Assets | |||
Gross Carrying Amount | $ 500 | $ 500 | |
Accumulated Amortization | (500) | (311) | |
Net Carrying Amount | $ 0 | $ 189 | |
Weighted Average Remaining Amortization Period (Years) | 0 years | 10 months 24 days |
Goodwill and Intangible Asset_4
Goodwill and Intangible Assets - Schedule of Expected Future Amortization Expense of Intangible Assets (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
2023 | $ 10,870,000 | ||
2024 | 7,527,000 | ||
2025 | 5,595,000 | ||
2026 | 4,200,000 | ||
2027 | 0 | ||
Thereafter | 0 | ||
Net Carrying Amount | 28,192,000 | $ 39,897,000 | $ 51,684,000 |
Impairment of intangible assets | $ 0 | $ 0 |
Debt - Convertible Senior Notes
Debt - Convertible Senior Notes and Capped Call (Narrative) (Details) | 1 Months Ended | 2 Months Ended | 3 Months Ended | 12 Months Ended | 39 Months Ended | ||||||
Dec. 30, 2022 $ / shares | Jan. 01, 2021 Rate | May 31, 2020 USD ($) shares | May 31, 2018 USD ($) $ / shares | Jun. 30, 2020 USD ($) $ / shares | Jun. 30, 2021 USD ($) | Dec. 31, 2022 USD ($) day $ / shares Rate shares | Dec. 31, 2021 USD ($) shares | Dec. 31, 2020 USD ($) shares | Sep. 30, 2022 USD ($) day trigger | May 21, 2020 $ / shares | |
Debt Instrument [Line Items] | |||||||||||
Debt balance | $ 747,700,000 | ||||||||||
Cash consideration to repurchase note | 34,067,000 | $ 24,688,000 | $ 200,350,000 | ||||||||
Loss on early extinguishment of debt | $ 0 | $ 0 | $ 6,964,000 | ||||||||
Common Stock | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares) | shares | 573,633 | 453,943 | 3,015,000 | ||||||||
Treasury Stock | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Partial unwind of capped calls related to the 2023 convertible senior notes (in shares) | shares | 119,492 | 68,905 | |||||||||
Convertible Senior Notes, Due 2023 | Treasury Stock | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Partial unwind of capped calls related to the 2023 convertible senior notes (in shares) | shares | 119,492 | 68,905 | |||||||||
Convertible Debt | Convertible Senior Notes, Due 2025 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Stated interest rate on debt (percent) | 0.50% | ||||||||||
Proceeds from issuance of debt | $ 728,800,000 | ||||||||||
Multiple of principle amount | $ 1,000 | ||||||||||
Conversion ratio on convertible debt | Rate | 744.37% | ||||||||||
Conversion price on convertible debt (in USD per share) | $ / shares | $ 134.34 | ||||||||||
Premium on conversion price in relation to closing price (percentage) | 30% | ||||||||||
Closing price of common stock (in dollars per share) | $ / shares | $ 67.86 | $ 103.34 | |||||||||
Share price of common stock with conversion premium (in dollars per share) | $ / shares | $ 174.64 | ||||||||||
Sinking fund payment | $ 0 | ||||||||||
Effective interest rate on debt (percent) | 5.76% | ||||||||||
Debt balance | $ 747,500,000 | $ 747,500,000 | |||||||||
Cap price of the capped call transactions (in dollars per share) | $ / shares | $ 206.68 | ||||||||||
Number of shares covered in the capped call transactions (in shares) | shares | 5,600,000 | ||||||||||
Amortization of debt issuance costs, effective interest rate | Rate | 1% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2025 | Fundamental Change Event | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt redemption price as percentage of principal amount | 100% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2025 | On or After June 6, 2023 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Number of trading days | day | 20 | ||||||||||
Number of consecutive trading days | day | 30 | ||||||||||
Number of trading days preceding notice of redemption | day | 2 | ||||||||||
Threshold percentage of stock price trigger | 130% | 130% | |||||||||
Debt redemption price as percentage of principal amount | 100% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2025 | Convertible, Term One | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Number of trading days | day | 20 | ||||||||||
Number of consecutive trading days | day | 30 | ||||||||||
Threshold percentage of stock price trigger | 130% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2025 | Convertible, Term Two | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Number of trading days | day | 5 | ||||||||||
Number of consecutive trading days | day | 5 | ||||||||||
Threshold percentage of stock price trigger | 98% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2023 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Stated interest rate on debt (percent) | 0.125% | ||||||||||
Proceeds from issuance of debt | $ 250,800,000 | ||||||||||
Multiple of principle amount | $ 1,000 | $ 1,000 | |||||||||
Conversion ratio on convertible debt | Rate | 2,449.78% | ||||||||||
Conversion price on convertible debt (in USD per share) | $ / shares | $ 40.82 | ||||||||||
Effective interest rate on debt (percent) | 6.39% | 5.32% | |||||||||
Convertible debt | $ 200,000 | ||||||||||
Debt balance | $ 169,000 | 34,225,000 | |||||||||
Cap price of the capped call transactions (in dollars per share) | $ / shares | $ 62.80 | ||||||||||
Number of shares covered in the capped call transactions (in shares) | shares | 6,300,000 | ||||||||||
Debt instrument, repurchase amount | $ 181,000,000 | ||||||||||
Aggregate consideration to repurchase note | 449,600,000 | ||||||||||
Cash consideration to repurchase note | 181,000,000 | ||||||||||
Debt instrument, convertible, carrying amount of debt component | 155,800,000 | ||||||||||
Carrying amount of equity component | 293,800,000 | ||||||||||
Carrying value of debt subject to repurchase, net | 150,400,000 | ||||||||||
Third party transaction costs | $ 500,000 | ||||||||||
Loss on early extinguishment of debt | $ 5,800,000 | $ 1,200,000 | |||||||||
Debt issuance costs, gross, within extinguishment of debt | $ 2,700,000 | ||||||||||
Number of conversion features triggered | trigger | 1 | ||||||||||
Conversion price per share requiring conversion (in USD per share) | $ / shares | $ 53.07 | ||||||||||
Cash payment to settle aggregate principal | $ 34,100,000 | 24,700,000 | |||||||||
Debt instrument, conversion multiple of aggregate principal amount | $ 34,100,000 | $ 24,600,000 | |||||||||
Amortization of debt issuance costs, effective interest rate | Rate | 0.76% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2023 | Common Stock | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Issuance of common stock upon partial conversion of the 2023 convertible senior notes (in shares) | shares | 2,723,581 | ||||||||||
Debt instrument, conversion multiple of aggregate principal amount (in shares) | shares | 573,633 | 453,943 | |||||||||
Convertible Debt | Convertible Senior Notes, Due 2023 | Fundamental Change Event | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Debt redemption price as percentage of principal amount | 100% | ||||||||||
Convertible Debt | Convertible Senior Notes, Due 2023 | Convertible, Term One | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Number of trading days | day | 20 | 20 | |||||||||
Number of consecutive trading days | day | 30 | 30 | |||||||||
Threshold percentage of stock price trigger | 130% | 130% | |||||||||
Convertible Debt | Convertible Senior Notes, Due 2023 | Convertible, Term Two | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Number of trading days | day | 5 | ||||||||||
Number of consecutive trading days | day | 5 | ||||||||||
Threshold percentage of stock price trigger | 98% | ||||||||||
Private Placement | Convertible Debt | Convertible Senior Notes, Due 2025 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Aggregate principal amount of debt | $ 747,500,000 | ||||||||||
Option to purchase additional debt through private offering | $ 97,500,000 | ||||||||||
Private Placement | Convertible Debt | Convertible Senior Notes, Due 2023 | |||||||||||
Debt Instrument [Line Items] | |||||||||||
Aggregate principal amount of debt | $ 258,800,000 |
Debt - Schedule of Net Carrying
Debt - Schedule of Net Carrying Amount of the Liability Component of the Notes (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Principal | $ 747,700 | |
Convertible Debt | Convertible Senior Notes, Due 2025 | ||
Debt Instrument [Line Items] | ||
Principal | 747,500 | $ 747,500 |
Unamortized issuance costs | (9,124) | (12,835) |
Net carrying amount | 738,376 | 734,665 |
Convertible Debt | Convertible Senior Notes, Due 2023 | ||
Debt Instrument [Line Items] | ||
Principal | 169 | 34,225 |
Unamortized issuance costs | 0 | (291) |
Net carrying amount | $ 169 | $ 33,934 |
Debt - Schedule of Interest Exp
Debt - Schedule of Interest Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2018 | |
Debt Instrument [Line Items] | ||||||||||||
Total interest expense | $ 1,887 | $ 1,879 | $ 1,857 | $ 1,870 | $ 2,024 | $ 1,947 | $ 2,118 | $ 1,938 | $ 7,493 | $ 8,027 | $ 28,348 | |
Convertible Senior Notes, Due 2025 | Convertible Debt | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Contractual interest expense | 3,737 | 4,007 | 2,230 | |||||||||
Amortization of debt discount | 0 | 0 | 16,528 | |||||||||
Amortization of issuance costs | 3,711 | 3,674 | 1,538 | |||||||||
Total interest expense | 7,448 | 7,681 | $ 20,296 | |||||||||
Convertible Senior Notes, Due 2023 | Convertible Debt | ||||||||||||
Debt Instrument [Line Items] | ||||||||||||
Contractual interest expense | 6 | 42 | $ 184 | |||||||||
Amortization of debt discount | 0 | 0 | 7,006 | |||||||||
Amortization of issuance costs | 32 | 283 | 666 | |||||||||
Total interest expense | $ 38 | $ 325 | $ 7,856 |
Stockholders' Equity - Capital
Stockholders' Equity - Capital Structure (Narrative) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Class of Stock [Line Items] | |||
Common stock, shares authorized (in shares) | 450,000,000 | 450,000,000 | |
Common stock, par value (in USD per share) | $ 0.001 | $ 0.001 | |
Common stock, shares issued (in shares) | 71,047,179 | 68,488,337 | |
Common stock, shares outstanding (in shares) | 71,047,179 | 68,488,337 | |
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 | |
Preferred stock, par value (in USD per share) | $ 0.001 | $ 0.001 | |
Preferred stock, shares issued (in shares) | 0 | 0 | |
Preferred stock, shares outstanding (in shares) | 0 | 0 | |
Common Stock | |||
Class of Stock [Line Items] | |||
Equity component from partial repurchase of 2023 convertible senior notes (in shares) | 573,633 | 453,943 | 3,015,000 |
Treasury Stock | |||
Class of Stock [Line Items] | |||
Partial unwind of capped calls related to the 2023 convertible senior notes (in shares) | 119,492 | 68,905 | |
Treasury Stock | Convertible Senior Notes, Due 2023 | |||
Class of Stock [Line Items] | |||
Partial unwind of capped calls related to the 2023 convertible senior notes (in shares) | 119,492 | 68,905 |
Stockholders' Equity - Schedule
Stockholders' Equity - Schedule of Common Stock Reserved for Future Issuance (Details) - shares | Dec. 31, 2022 | Apr. 03, 2014 |
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 22,999,000 | |
Shares available for future grant under 2014 Plan | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 14,230,000 | |
Stock options outstanding | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 1,481,000 | |
RSUs (including PRSUs) outstanding | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 3,718,000 | |
Shares available for future issuance under ESPP | ||
Class of Stock [Line Items] | ||
Shares of common stock reserved for future issuance (in shares) | 3,570,000 | 880,000 |
Stockholders' Equity - Equity I
Stockholders' Equity - Equity Incentive Plans (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||||
Nov. 18, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Mar. 31, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Recognized goodwill in relation to options assumed | $ 165,420 | $ 165,420 | |||
Stock-based compensation expense | $ 172,507 | $ 108,805 | $ 64,747 | ||
Inference Solutions | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Recognized goodwill in relation to options assumed | $ 130,976 | ||||
Stock Option | Inference Solutions | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Options assumed, estimated fair value on date of acquisition | 7,600 | ||||
Recognized goodwill in relation to options assumed | 200 | ||||
Stock-based compensation expense | $ 7,400 | ||||
2004 Equity Incentive Plan | Stock Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 4 years | ||||
Award expiration period (in years) | 10 years | ||||
Expiration period, after termination of employment or relationship of consultant or director | 90 days | ||||
2004 Equity Incentive Plan | Stock Option | Tranche One | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 12 months | ||||
Award vesting, percentage of award | 25% | ||||
2004 Equity Incentive Plan | Stock Option | Tranche Two | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 36 months | ||||
Award vesting, percentage of award | 75% | ||||
2014 Equity Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Number of shares authorized for issuance (in shares) | 5,300,000 | ||||
Automatic annual increase in common stock reserved for issuance, percentage | 5% | ||||
Shares of common stock reserved for future issuance (in shares) | 3,552,358 | ||||
2014 Equity Incentive Plan | Stock Option | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 4 years | ||||
Award expiration period (in years) | 10 years | ||||
Expiration period, after termination of employment or relationship of consultant or director | 3 months | ||||
2014 Equity Incentive Plan | RSUs (including PRSUs) | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 1 year | ||||
2014 Equity Incentive Plan | RSUs (including PRSUs) | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award | |||||
Award vesting period (in years) | 4 years |
Stockholders' Equity - Schedu_2
Stockholders' Equity - Schedule of Stock Option Activities (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 30, 2022 | |
Additional information pertaining to stock options | ||||
Fair market value of common stock (in usd per share) | $ 67.86 | |||
Stock Option | ||||
Number of Shares | ||||
Outstanding, beginning balance (in shares) | 1,982 | |||
Options granted (in shares) | 81 | |||
Options exercised (in shares) | (531) | |||
Options forfeited or expired (in shares) | (51) | |||
Outstanding, ending balance (in shares) | 1,481 | 1,982 | ||
Weighted Average Exercise Price | ||||
Outstanding, beginning balance, weighted-average exercise price (in USD per share) | $ 38.65 | |||
Options granted, weighted-average exercise price (in USD per share) | 110.05 | |||
Options exercised, weighted-average exercise price (in USD per share) | 16.06 | |||
Options forfeited or expired, weighted-average exercise price (in USD per share) | 122.88 | |||
Outstanding, ending balance, weighted-average exercise price (in USD per share) | $ 47.75 | $ 38.65 | ||
Weighted average remaining contractual life | 4 years 7 months 6 days | |||
Outstanding, aggregate intrinsic value | $ 51,226 | |||
Vested and expected to vest | ||||
Vested and expected to vest (in shares) | 1,481 | |||
Outstanding, weighted-average exercise price (in USD per share) | $ 47.75 | |||
Outstanding, weighted average remaining contractual life | 4 years 7 months 6 days | |||
Vested and expected to vest, aggregate intrinsic value | $ 51,226 | |||
Additional information pertaining to stock options | ||||
Exercisable (in shares) | 1,263 | |||
Exercisable, weighted-average exercise price (in USD per share) | $ 35.60 | |||
Exercisable, weighted average remaining contractual life | 4 years | |||
Exercisable, aggregate intrinsic value | $ 50,583 | |||
Weighted average grant date fair value per share of options granted, excluding assumed stock options (in USD per share) | $ 50.44 | 78.72 | $ 38.80 | |
Weighted average grant date fair value per share of assumed stock options (in USD per share) | $ 0 | $ 0 | $ 125,960 | |
Intrinsic value of options exercised | $ 45,698 | $ 59,762 | $ 47,529 | |
Total fair value of options vested during the period | 11,421 | 12,760 | 7,846 | |
Cash received from options exercised | $ 8,522 | $ 7,402 | $ 11,656 |
Stockholders' Equity - Schedu_3
Stockholders' Equity - Schedule of RSU Activities (Details) - RSUs (including PRSUs) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Number of Shares | |||
Outstanding, beginning balance (in shares) | 2,560 | ||
RSUs granted (in shares) | 2,912 | ||
RSUs vested and released (in shares) | (1,383) | ||
RSUs forfeited or cancelled (in shares) | (371) | ||
Outstanding, ending balance (in shares) | 3,718 | 2,560 | |
Weighted Average Grant Date Fair Value Per Share | |||
Outstanding, beginning balance, weighted-average grant date fair value per share (in USD per share) | $ 125.65 | ||
RSUs granted (in USD per share) | 90.51 | $ 177 | $ 86.15 |
RSUs vested and released, weighted-average grant date fair value per share (in USD per share) | 112.18 | ||
RSUs forfeited or cancelled, weighted-average grant date fair value per share (in USD per share) | 121.48 | ||
Outstanding, ending balance, weighted-average grant date fair value per share (in USD per share) | 103.55 | 125.65 | |
Weighted average grant date fair value per share of RSUs granted | $ 90.51 | $ 177 | $ 86.15 |
Total fair value of RSUs vested during the period | $ 125,798 | $ 174,500 | $ 136,805 |
Stockholders' Equity - Performa
Stockholders' Equity - Performance-Based Restricted Stock Units (Narrative) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) goal installment period shares | |
Market-Based PRSUs | |
Stockholders' Equity Capital Structure [Line Items] | |
Equity instruments granted (in shares) | shares | 300,000 |
Equity instruments granted, weighted average grant date fair value | $ 30.6 |
Market-Based PRSUs | Tranche One | |
Stockholders' Equity Capital Structure [Line Items] | |
Target level qualifying termination of employment | 0.1 |
Market-Based PRSUs | Tranche Two | |
Stockholders' Equity Capital Structure [Line Items] | |
Target level qualifying termination of employment | $ 0.2 |
Performance-Based Restricted Stock Units (PRSUs) | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 0.3333 |
Number of performance periods | period | 3 |
Term of the performance period (in years) | 1 year |
Performance periods limited to 100% of target | period | 2 |
Earnout target percentage, maximum for 2022 and 2023 (as a percent) | 1 |
Performance-Based Restricted Stock Units (PRSUs) | Minimum | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 0 |
Performance-Based Restricted Stock Units (PRSUs) | Maximum | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 2 |
Performance-Based Restricted Stock Units (PRSUs) | Maximum | Shareholder for Performance Any Period is Negative | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 1 |
Performance-Based Restricted Stock Units (PRSUs) | Maximum | Executive Employment Terminates due to Death by end of 2024 | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 1 |
Performance-Based Restricted Stock Units (PRSUs) | Maximum | Executive Employment Terminates due to Disability by end of 2024 | |
Stockholders' Equity Capital Structure [Line Items] | |
Earnout target percentage (as a percent) | 0.50 |
Revenue-Based PRSUs | |
Stockholders' Equity Capital Structure [Line Items] | |
Equity instruments granted (in shares) | shares | 100,000 |
Equity instruments granted, weighted average grant date fair value | $ 6.6 |
Earnout target percentage (as a percent) | 0.6666 |
Number of quarterly revenue goals | goal | 2 |
Revenue-Based PRSUs | Tranche One | |
Stockholders' Equity Capital Structure [Line Items] | |
Number of quarterly installments | installment | 4 |
Revenue-Based PRSUs | Tranche Two | |
Stockholders' Equity Capital Structure [Line Items] | |
Number of quarterly installments | installment | 8 |
Stockholders' Equity - ESPP (Na
Stockholders' Equity - ESPP (Narrative) (Details) - $ / shares | 1 Months Ended | 12 Months Ended | ||
Mar. 31, 2014 | Dec. 31, 2022 | Dec. 31, 2021 | Apr. 03, 2014 | |
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Shares of common stock reserved for future issuance (in shares) | 22,999,000 | |||
PRSU | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Maximum employee subscription rate, percentage of pre-tax earnings | 15% | |||
Purchase price of shares, percentage of the fair market value of the Company's common stock | 85% | |||
Offering period (in months) | 6 months | |||
Maximum number of shares per employee per purchase period (in shares) | 1,500 | |||
Shares of common stock reserved for future issuance (in shares) | 3,570,000 | 880,000 | ||
Automatic annual increase in common stock reserved for issuance, percentage | 1% | |||
Maximum annual increase of shares reserved (in shares) | 1,000,000 | |||
Shares of common stock reserved for future issuance (in shares) | 710,471 | |||
Issuance of common stock under ESPP (in shares) | 190,257 | 120,992 | ||
Weighted-average price per share (in USD per share) | $ 70.50 | $ 127.36 |
Stockholders' Equity - Schedu_4
Stockholders' Equity - Schedule of Stock-Based Compensation (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Stock-based Compensation Expense | |||
Stock-based compensation expense | $ 172,507 | $ 108,805 | $ 64,747 |
Stock Option | |||
Stock-based Compensation Expense | |||
Unrecognized stock-based compensation expense | $ 12,085 | ||
Weighted-average amortization period | 2 years 2 months 12 days | ||
RSUs (including PRSUs) | |||
Stock-based Compensation Expense | |||
Unrecognized stock-based compensation expense | $ 324,834 | ||
Weighted-average amortization period | 2 years 4 months 24 days | ||
Equity instruments granted (in shares) | 2,912,000 | ||
PRSU | |||
Stock-based Compensation Expense | |||
Unrecognized stock-based compensation expense | $ 24,841 | ||
Weighted-average amortization period | 2 years 6 months | ||
PRSU | |||
Stock-based Compensation Expense | |||
Unrecognized stock-based compensation expense | $ 3,265 | ||
Weighted-average amortization period | 4 months 24 days | ||
Performance-Based and Market Based Restricted Stock Units (PRSUs) | |||
Stock-based Compensation Expense | |||
Equity instruments granted (in shares) | 400,000 | ||
Cost of revenue | |||
Stock-based Compensation Expense | |||
Stock-based compensation expense | $ 33,297 | 17,734 | 9,422 |
Research and development | |||
Stock-based Compensation Expense | |||
Stock-based compensation expense | 44,367 | 29,179 | 14,043 |
Sales and marketing | |||
Stock-based Compensation Expense | |||
Stock-based compensation expense | 59,300 | 35,269 | 20,164 |
General and administrative | |||
Stock-based Compensation Expense | |||
Stock-based compensation expense | $ 35,543 | $ 26,623 | $ 21,118 |
Stockholders' Equity - Schedu_5
Stockholders' Equity - Schedule of Option and ESPP Valuation Assumptions (Details) | 1 Months Ended | 12 Months Ended | |||||||
Nov. 30, 2022 | May 31, 2022 | Nov. 30, 2021 | May 31, 2021 | Nov. 30, 2020 | May 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Stock Options and Purchase Rights | |||||||||
Class of Stock [Line Items] | |||||||||
Expected term (years) | 6 years | 6 years | 5 years 8 months 12 days | ||||||
Volatility | 46% | 47% | 47% | ||||||
Risk-free interest rate | 1.80% | 1% | 0.90% | ||||||
Dividend yield | 0% | 0% | 0% | ||||||
Purchase Rights | |||||||||
Class of Stock [Line Items] | |||||||||
Expected term (years) | 6 years | ||||||||
Volatility | 47% | ||||||||
Risk-free interest rate | 1% | ||||||||
Dividend yield | 0% | ||||||||
Stock Option | |||||||||
Class of Stock [Line Items] | |||||||||
Expected term (years) | 4 years 3 months 18 days | ||||||||
Volatility | 47% | ||||||||
Risk-free interest rate | 0.30% | ||||||||
Dividend yield | 0% | ||||||||
Performance-Based Restricted Stock Units (PRSUs) | |||||||||
Class of Stock [Line Items] | |||||||||
Expected term (years) | 3 years | ||||||||
Volatility | 53% | ||||||||
Risk-free interest rate | 3.50% | ||||||||
Dividend yield | 0% | ||||||||
PRSU | |||||||||
Class of Stock [Line Items] | |||||||||
Expected term (years) | 6 months | 6 months | 6 months | 6 months | 6 months | 6 months | |||
Volatility | 59% | 46% | 46% | 49% | 50% | 50% | |||
Risk-free interest rate | 2.10% | 0.20% | 0.20% | 0.10% | 0.10% | 0.20% | |||
Dividend yield | 0% | 0% | 0% | 0% | 0% | 0% |
Net Loss Per Share - Schedule o
Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | |||||||||||
Net loss | $ (13,653) | $ (23,207) | $ (23,670) | $ (34,120) | $ (3,601) | $ (20,537) | $ (16,530) | $ (12,332) | $ (94,650) | $ (53,000) | $ (42,130) |
Weighted-average shares used in computing basic net loss per share (in shares) | 70,704 | 70,232 | 69,748 | 68,974 | 68,207 | 67,800 | 67,292 | 66,721 | 69,920 | 67,512 | 64,154 |
Weighted-average shares used in computing diluted net loss per share (in shares) | 70,704 | 70,232 | 69,748 | 68,974 | 68,207 | 67,800 | 67,292 | 66,721 | 69,920 | 67,512 | 64,154 |
Basic net loss per share (in USD per share) | $ (0.19) | $ (0.33) | $ (0.34) | $ (0.49) | $ (0.05) | $ (0.30) | $ (0.25) | $ (0.18) | $ (1.35) | $ (0.79) | $ (0.66) |
Diluted net loss per share (in USD per share) | $ (0.19) | $ (0.33) | $ (0.34) | $ (0.49) | $ (0.05) | $ (0.30) | $ (0.25) | $ (0.18) | $ (1.35) | $ (0.79) | $ (0.66) |
Net Loss Per Share - Schedule_2
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share | |||
Total (in shares) | 10,884 | 11,205 | 5,432 |
Stock Option | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share | |||
Total (in shares) | 1,481 | 1,982 | 2,255 |
RSUs (including PRSUs) | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share | |||
Total (in shares) | 3,718 | 2,560 | 2,267 |
Convertible Senior Notes | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share | |||
Total (in shares) | 5,685 | 6,663 | 910 |
Net Loss Per Share - Narrative
Net Loss Per Share - Narrative (Details) | Dec. 31, 2022 $ / shares |
Convertible Senior Notes, Due 2023 | Convertible Debt | |
Debt Instrument [Line Items] | |
Conversion price on convertible debt (in USD per share) | $ 40.82 |
Income Taxes - Schedule of Comp
Income Taxes - Schedule of Components of Loss Before Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||||||||||
United States | $ (76,280) | $ (59,856) | $ (44,303) | ||||||||
International | (13,982) | (4,429) | (280) | ||||||||
Loss before income taxes | $ (12,432) | $ (22,628) | $ (23,338) | $ (31,864) | $ (14,046) | $ (20,725) | $ (16,665) | $ (12,849) | $ (90,262) | $ (64,285) | $ (44,583) |
Income Taxes - Schedule of Co_2
Income Taxes - Schedule of Components of Provision for Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Current: | |||||||||||
U.S. federal | $ 0 | $ 0 | $ 0 | ||||||||
U.S. state | 576 | 262 | 401 | ||||||||
Foreign | 724 | (202) | 233 | ||||||||
Total provision for income taxes - Current | 1,300 | 60 | 634 | ||||||||
Deferred: | |||||||||||
U.S. federal | 0 | 0 | (2,495) | ||||||||
U.S. state | 0 | 0 | (414) | ||||||||
Foreign | 3,088 | (11,345) | (178) | ||||||||
Total provision for (benefit from) income taxes - Deferred | 3,088 | (11,345) | (3,087) | ||||||||
Total provision for (benefit from) income taxes | $ 1,221 | $ 579 | $ 332 | $ 2,256 | $ (10,445) | $ (188) | $ (135) | $ (517) | $ 4,388 | $ (11,285) | $ (2,453) |
Income Taxes - Schedule of Effe
Income Taxes - Schedule of Effective Income Tax Amount Reconciliation (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||||||||||
U.S. federal tax at statutory rate | $ (18,957) | $ (13,500) | $ (9,362) | ||||||||
U.S. state income taxes | 576 | 262 | (345) | ||||||||
Section 162(m) | 3,851 | 7,543 | 6,472 | ||||||||
Global intangible low-taxed income | 4,127 | 0 | 0 | ||||||||
Non-deductible expenses | 78 | 1,361 | 1,944 | ||||||||
Research and development credit | (1,194) | (1,181) | (837) | ||||||||
Stock-based compensation | 1,722 | (25,241) | (23,800) | ||||||||
Tax benefit from acquisition/reorganizations | (3,852) | (5,877) | (2,495) | ||||||||
Foreign taxes | 6,749 | (4,760) | 118 | ||||||||
Other | 0 | 20 | 533 | ||||||||
Change in valuation allowance | 11,288 | 30,088 | 25,319 | ||||||||
Total provision for (benefit from) income taxes | $ 1,221 | $ 579 | $ 332 | $ 2,256 | $ (10,445) | $ (188) | $ (135) | $ (517) | $ 4,388 | $ (11,285) | $ (2,453) |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Deferred tax assets: | ||
Net operating loss and credit carryforwards | $ 125,698 | $ 133,433 |
Capitalized R&D costs | 30,552 | 0 |
Accrued liabilities | 10,295 | 12,719 |
Allowance for doubtful accounts | 1,143 | 712 |
Amortized intangibles | 3,041 | 872 |
Deferred revenue | 1,992 | 1,351 |
Accrued compensation | 3,238 | 3,963 |
Long-term lease liabilities | 12,421 | 13,618 |
Gross deferred tax assets | 188,380 | 166,668 |
Valuation allowance | (135,406) | (121,835) |
Net deferred tax assets | 52,974 | 44,833 |
Deferred tax liabilities: | ||
Property and equipment | (2,737) | (2,633) |
Other | (556) | (509) |
Right of use assets | (10,419) | (11,573) |
Deferred compensation - Current | (35,443) | (23,211) |
Gross deferred tax liabilities | (49,155) | (37,926) |
Net deferred taxes | $ 3,819 | $ 6,907 |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Loss Carryforwards [Line Items] | ||
U.S. federal income tax rate (percent) | 21% | |
Deferred tax assets | $ 3,819 | $ 6,907 |
Limitation on use of net operating loss, cumulative ownership change, more than | 50% | |
Limitation on use of net operating loss, cumulative ownership change, period of change (in years) | 3 years | |
Unrecognized tax benefits that would impact effective tax rate | $ 0 | 0 |
U.K. and Australia | ||
Operating Loss Carryforwards [Line Items] | ||
Deferred tax assets | 3,800 | 6,900 |
Federal | ||
Operating Loss Carryforwards [Line Items] | ||
Increase (decrease) in valuation allowance for deferred tax assets | 13,600 | $ 70,700 |
Net operating loss carryforwards | 456,900 | |
Federal | Research and Development Tax Credit Carryforward | ||
Operating Loss Carryforwards [Line Items] | ||
Research and development credit carryforwards | 10,800 | |
State | ||
Operating Loss Carryforwards [Line Items] | ||
Net operating loss carryforwards | 310,900 | |
State | Research and Development Tax Credit Carryforward | ||
Operating Loss Carryforwards [Line Items] | ||
Research and development credit carryforwards | 7,000 | |
Foreign Tax Authority | ||
Operating Loss Carryforwards [Line Items] | ||
Net operating loss carryforwards | $ 13,500 |
Income Taxes - Schedule of Unre
Income Taxes - Schedule of Unrecognized Tax Benefits Rollforward (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Reconciliation of Unrecognized Tax Benefits | |||
Unrecognized benefit — beginning of period | $ 7,643 | $ 6,076 | $ 4,471 |
Gross increases — current year tax positions | 1,773 | 1,851 | 1,605 |
Gross decreases — prior year tax positions | (1) | 0 | 0 |
Settlements with tax authorities | 0 | (284) | 0 |
Unrecognized benefit — end of period | $ 9,415 | $ 7,643 | $ 6,076 |
Commitments and Contingencies -
Commitments and Contingencies - Commitments (Narrative) (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Other Commitments [Line Items] | |
Debt balance | $ 747,700 |
Outstanding operating lease obligations | 57,854 |
Purchase Commitment - Cloud Services Agreement | |
Other Commitments [Line Items] | |
Expiring commercial commitment balance | 41,100 |
Commercial commitment to be paid year one | 29,000 |
Commercial commitment to be paid year two | $ 12,100 |
Commitments and Contingencies_2
Commitments and Contingencies - Schedule of Future Minimum Lease Payments for Hosting, Telecommunication Usage Services (Details) $ in Thousands | Dec. 31, 2022 USD ($) |
Hosting Services | |
Unrecorded Unconditional Purchase Obligation [Line Items] | |
2023 | $ 588 |
2024 | 238 |
2025 | 4 |
2026 | 0 |
Thereafter | 0 |
Total future minimum payment | 830 |
Telecommunication Usage Services | |
Unrecorded Unconditional Purchase Obligation [Line Items] | |
2023 | 7,467 |
2024 | 5,940 |
2025 | 1,304 |
2026 | 459 |
Thereafter | 0 |
Total future minimum payment | $ 15,170 |
Commitments and Contingencies_3
Commitments and Contingencies - Universal Services Fund Liability (Narrative) (Details) $ in Millions | Dec. 31, 2022 USD ($) |
Disputed Portion | Year 2003 to Year 2007 | USF Obligations | |
Loss Contingencies [Line Items] | |
Disputed liability related to reversal of interest and penalties | $ 0.1 |
Commitments and Contingencies_4
Commitments and Contingencies - State and Local Taxes and Surcharges (Narrative) (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Loss Contingencies [Line Items] | ||
Sales tax liability - current | $ 2,973 | $ 2,660 |
Contingent Sales Tax Liabilities | ||
Loss Contingencies [Line Items] | ||
Sales tax liability | 1,200 | 1,000 |
Sales tax liability - current | $ 300 | $ 200 |
Geographical Information - Sche
Geographical Information - Schedule of Revenue and Property and Equipment by Geographic Region (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues from External Customers and Long-Lived Assets | |||||||||||
Revenue | $ 208,345 | $ 198,342 | $ 189,382 | $ 182,777 | $ 173,599 | $ 154,328 | $ 143,782 | $ 137,882 | $ 778,846 | $ 609,591 | $ 434,908 |
Property and equipment, net | 101,221 | 77,785 | 101,221 | 77,785 | |||||||
United States | |||||||||||
Revenues from External Customers and Long-Lived Assets | |||||||||||
Revenue | 702,206 | 556,385 | 400,509 | ||||||||
Property and equipment, net | 92,659 | 68,674 | 92,659 | 68,674 | |||||||
International | |||||||||||
Revenues from External Customers and Long-Lived Assets | |||||||||||
Revenue | 76,640 | 53,206 | $ 34,399 | ||||||||
Property and equipment, net | $ 8,562 | $ 9,111 | $ 8,562 | $ 9,111 |
Retirement Plans (Details)
Retirement Plans (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Retirement Benefits [Abstract] | |||
Contribution expense | $ 2.1 | $ 1.8 | |
Requisite service period (in years) | 5 years | ||
Defined benefit liability | $ 0.5 | 0.6 | |
Retirement expense | $ 0.2 | $ 0.2 | $ 0.1 |
Leases - Narrative (Details)
Leases - Narrative (Details) | 12 Months Ended |
Dec. 31, 2022 | |
Lessee, Lease, Description [Line Items] | |
Operating lease, termination notice, period (in days) | 30 days |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Operating lease, term of contract (in years) | 1 year |
Operating lease, extension term (in years) | 3 years |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Operating lease, term of contract (in years) | 10 years |
Operating lease, extension term (in years) | 5 years |
Leases - Schedule of Lease Cost
Leases - Schedule of Lease Cost and Supplemental Cash Flow (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Leases [Abstract] | |||
Operating lease cost | $ 12,072 | $ 10,238 | $ 6,142 |
Finance lease cost: | |||
Amortization of right-of-use assets | 56 | 438 | 748 |
Interest on finance lease liabilities | 0 | 0 | 212 |
Total finance lease cost | 56 | 438 | 960 |
Cash paid for amounts included in the measurement of lease liabilities: | |||
Operating cash used in operating leases | (11,684) | (7,178) | (6,531) |
Financing cash used in finance leases | 0 | (612) | (3,715) |
Right of use assets obtained in exchange for lease obligations: | |||
Operating leases | 5,984 | 50,101 | 5,980 |
Finance leases | $ 0 | $ 0 | $ 0 |
Leases - Schedule of Balance Sh
Leases - Schedule of Balance Sheet Disclosures (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Operating leases | ||
Operating lease right-of-use assets | $ 44,120 | $ 48,703 |
Operating lease liabilities: | ||
Operating lease liabilities | 10,626 | 9,826 |
Operating lease liabilities — less current portion | 41,389 | 47,088 |
Total operating lease liabilities | 52,015 | 56,914 |
Finance leases | ||
Property and equipment, gross | 36,282 | 42,541 |
Less: accumulated depreciation and amortization | (36,203) | (41,689) |
Property and equipment, net | $ 79 | $ 852 |
Finance lease, right-of-use asset, Balance Sheet location [Extensible Enumeration] | Property and equipment, net | Property and equipment, net |
Leases - Schedule of Weighted A
Leases - Schedule of Weighted Average Remaining Terms and Discount Rates (Details) | Dec. 31, 2022 | Dec. 31, 2021 |
Leases [Abstract] | ||
Weighted average remaining lease term, operating leases (in years) | 6 years 4 months 24 days | 7 years 3 months 18 days |
Weighted average remaining lease term, finance leases (in years) | 0 years | 0 years |
Weighted average discount rate, operating leases | 3.40% | 3.20% |
Weighted average discount rate, finance leases | 0% | 0% |
Leases - Schedule of Lease Matu
Leases - Schedule of Lease Maturities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Operating Leases | ||
2023 | $ 12,246 | |
2024 | 9,986 | |
2025 | 7,144 | |
2026 | 5,679 | |
2027 | 5,718 | |
Thereafter | 17,081 | |
Total future minimum lease payments | 57,854 | |
Less: imputed interest | (5,839) | |
Total | $ 52,015 | $ 56,914 |
Acquisitions - Inference Soluti
Acquisitions - Inference Solutions (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||||
Nov. 18, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Nov. 30, 2020 | |
Business Acquisition [Line Items] | |||||
Cash paid to acquire Virtual Observer | $ 0 | $ 0 | $ 165,338 | ||
Contingent consideration | 23,740 | ||||
Payment for contingent consideration liability | 18,100 | 0 | $ 0 | ||
Goodwill | 165,420 | $ 165,420 | |||
Inference Solutions | |||||
Business Acquisition [Line Items] | |||||
Cash consideration | $ 156,700 | ||||
Cash paid to acquire Virtual Observer | 137,000 | ||||
Contingent consideration | 18,100 | $ 24,000 | |||
Contingent consideration, range of outcomes, low | 0 | ||||
Contingent consideration, range of outcomes, high | 24,000 | ||||
Payment for contingent consideration liability | 24,000 | ||||
Goodwill | $ 130,976 | ||||
Inference Solutions | Acquired technology | |||||
Business Acquisition [Line Items] | |||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 6 years | ||||
Inference Solutions | Customer relationships | |||||
Business Acquisition [Line Items] | |||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 5 years | ||||
Inference Solutions | Trade name and trademarks | |||||
Business Acquisition [Line Items] | |||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 2 years | ||||
Inference Solutions | Maximum | |||||
Business Acquisition [Line Items] | |||||
Contingent consideration | $ 24,000 |
Acquisitions - Schedule of Infe
Acquisitions - Schedule of Inference Solutions (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Nov. 18, 2020 |
Business Acquisition [Line Items] | |||
Goodwill | $ 165,420 | $ 165,420 | |
Inference Solutions | |||
Business Acquisition [Line Items] | |||
Cash | $ 1,394 | ||
Property and equipment acquired | 124 | ||
Other assets acquired | 2,238 | ||
Goodwill | 130,976 | ||
Total assets acquired | 164,832 | ||
Liabilities assumed | (3,525) | ||
Deferred tax liability | (4,616) | ||
Total | 156,691 | ||
Total consideration (net of cash acquired) | 155,297 | ||
Inference Solutions | Acquired technology | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | 28,600 | ||
Inference Solutions | Customer relationships | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | 1,100 | ||
Inference Solutions | Trade name and trademarks | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | $ 400 |
Acquisitions - Virtual Observer
Acquisitions - Virtual Observer (Narrative) (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Apr. 01, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | ||||
Cash paid to acquire Inference Solutions | $ 0 | $ 0 | $ 165,338 | |
Goodwill | $ 165,420 | $ 165,420 | ||
Virtual Observer | ||||
Business Acquisition [Line Items] | ||||
Cash paid to acquire Inference Solutions | $ 32,200 | |||
Goodwill | $ 22,646 | |||
Virtual Observer | Acquired technology | ||||
Business Acquisition [Line Items] | ||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 5 years | |||
Virtual Observer | Customer relationships | ||||
Business Acquisition [Line Items] | ||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 5 years | |||
Virtual Observer | Trade name and trademarks | ||||
Business Acquisition [Line Items] | ||||
Acquired finite-lived intangible assets, weighted average useful life (years) | 2 years |
Acquisitions - Schedule of Virt
Acquisitions - Schedule of Virtual Observer (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Apr. 01, 2020 |
Business Acquisition [Line Items] | |||
Goodwill | $ 165,420 | $ 165,420 | |
Virtual Observer | |||
Business Acquisition [Line Items] | |||
Cash | $ 168 | ||
Tangible assets acquired | 200 | ||
Goodwill | 22,646 | ||
Total assets acquired | 35,814 | ||
Deferred tax liability | (2,910) | ||
Liabilities assumed | (682) | ||
Total | 32,222 | ||
Virtual Observer | Acquired technology | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | 12,200 | ||
Virtual Observer | Customer relationships | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | 500 | ||
Virtual Observer | Trade name and trademarks | |||
Business Acquisition [Line Items] | |||
Finite-lived intangibles acquired | $ 100 |
Selected Quarterly Financial _3
Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Revenue | $ 208,345 | $ 198,342 | $ 189,382 | $ 182,777 | $ 173,599 | $ 154,328 | $ 143,782 | $ 137,882 | $ 778,846 | $ 609,591 | $ 434,908 |
Cost of revenue | 96,294 | 94,111 | 88,229 | 88,867 | 79,764 | 67,137 | 64,395 | 59,803 | 367,501 | 271,099 | 180,284 |
Gross profit | 112,051 | 104,231 | 101,153 | 93,910 | 93,835 | 87,191 | 79,387 | 78,079 | 411,345 | 338,492 | 254,624 |
Operating expenses: | |||||||||||
Research and development | 36,865 | 34,113 | 34,992 | 35,824 | 30,448 | 29,680 | 24,648 | 22,121 | 141,794 | 106,897 | 68,747 |
Sales and marketing | 65,928 | 67,353 | 64,098 | 64,611 | 53,394 | 49,712 | 46,024 | 44,799 | 261,990 | 193,929 | 132,413 |
General and administrative | 22,509 | 24,496 | 23,824 | 24,314 | 21,972 | 26,790 | 22,909 | 22,245 | 95,143 | 93,916 | 65,769 |
Total operating expenses | 125,302 | 125,962 | 122,914 | 124,749 | 105,814 | 106,182 | 93,581 | 89,165 | 498,927 | 394,742 | 266,929 |
Loss from operations | (13,251) | (21,731) | (21,761) | (30,839) | (11,979) | (18,991) | (14,194) | (11,086) | (87,582) | (56,250) | (12,305) |
Other (expense) income, net: | |||||||||||
Interest expense | (1,887) | (1,879) | (1,857) | (1,870) | (2,024) | (1,947) | (2,118) | (1,938) | (7,493) | (8,027) | (28,348) |
Other (expense) and interest income | 2,706 | 982 | 280 | 845 | (43) | 213 | (353) | 175 | 4,813 | (8) | 3,034 |
Total other (expense) income, net | 819 | (897) | (1,577) | (1,025) | (2,067) | (1,734) | (2,471) | (1,763) | (2,680) | (8,035) | (32,278) |
Loss before income taxes | (12,432) | (22,628) | (23,338) | (31,864) | (14,046) | (20,725) | (16,665) | (12,849) | (90,262) | (64,285) | (44,583) |
Provision for (benefit from) income taxes | 1,221 | 579 | 332 | 2,256 | (10,445) | (188) | (135) | (517) | 4,388 | (11,285) | (2,453) |
Net loss | $ (13,653) | $ (23,207) | $ (23,670) | $ (34,120) | $ (3,601) | $ (20,537) | $ (16,530) | $ (12,332) | $ (94,650) | $ (53,000) | $ (42,130) |
Net loss per share: | |||||||||||
Basic (in USD per share) | $ (0.19) | $ (0.33) | $ (0.34) | $ (0.49) | $ (0.05) | $ (0.30) | $ (0.25) | $ (0.18) | $ (1.35) | $ (0.79) | $ (0.66) |
Diluted (in USD per share) | $ (0.19) | $ (0.33) | $ (0.34) | $ (0.49) | $ (0.05) | $ (0.30) | $ (0.25) | $ (0.18) | $ (1.35) | $ (0.79) | $ (0.66) |
Shares used in computing net loss per share: | |||||||||||
Basic (in shares) | 70,704 | 70,232 | 69,748 | 68,974 | 68,207 | 67,800 | 67,292 | 66,721 | 69,920 | 67,512 | 64,154 |
Diluted (in shares) | 70,704 | 70,232 | 69,748 | 68,974 | 68,207 | 67,800 | 67,292 | 66,721 | 69,920 | 67,512 | 64,154 |
Selected Quarterly Financial _4
Selected Quarterly Financial Data (Unaudited) - Schedule of Allocation of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Quarterly Financial Information [Line Items] | |||||||||||
Total stock-based compensation | $ 43,824 | $ 44,503 | $ 44,786 | $ 39,394 | $ 35,601 | $ 27,395 | $ 24,901 | $ 20,908 | $ 172,507 | $ 108,805 | $ 64,747 |
Cost of revenue | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total stock-based compensation | 8,638 | 8,329 | 8,538 | 7,793 | 6,854 | 3,994 | 3,781 | 3,105 | |||
Research and development | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total stock-based compensation | 11,799 | 10,603 | 11,818 | 10,145 | 9,163 | 9,101 | 6,152 | 4,763 | |||
Sales and marketing | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total stock-based compensation | 15,152 | 15,761 | 14,963 | 13,424 | 11,987 | 8,304 | 8,208 | 6,771 | |||
General and administrative | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total stock-based compensation | $ 8,235 | $ 9,810 | $ 9,467 | $ 8,032 | $ 7,597 | $ 5,996 | $ 6,760 | $ 6,269 |
Selected Quarterly Financial _5
Selected Quarterly Financial Data (Unaudited) - Schedule of Allocation of Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Quarterly Financial Information [Line Items] | |||||||||||
Total depreciation and amortization | $ 11,021 | $ 11,215 | $ 11,640 | $ 10,795 | $ 10,538 | $ 9,780 | $ 9,651 | $ 8,763 | $ 44,671 | $ 38,732 | $ 25,087 |
Cost of revenue | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total depreciation and amortization | 8,803 | 8,904 | 8,747 | 8,500 | 8,301 | 7,658 | 7,825 | 7,087 | |||
Research and development | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total depreciation and amortization | 768 | 768 | 804 | 825 | 948 | 1,004 | 729 | 596 | |||
Sales and marketing | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total depreciation and amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||
General and administrative | |||||||||||
Quarterly Financial Information [Line Items] | |||||||||||
Total depreciation and amortization | $ 1,449 | $ 1,542 | $ 2,088 | $ 1,469 | $ 1,288 | $ 1,117 | $ 1,096 | $ 1,079 |
Uncategorized Items - fivn-2022
Label | Element | Value |
Restricted Cash and Cash Equivalents | us-gaap_RestrictedCashAndCashEquivalents | $ 0 |